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ABSTRACT

PSYCHOSOCIAL DETERMINANTS OF MEDICATION ADHERENCE IN HIV-POSITIVE
INDIVIDUALS IN MEXICO CITY

Anthony J. Vajda
Old Dominion University, 2018
Chair: Dr. Kaprea Johnson

This dissertation examined the relationships among disclosure, social support, exposure to
violence, impulsivity, depression, stressors, and medication adherence, using a correlational
design and a sequential logistic regression. The researcher used two samples of 146 from an
archival data set of participants to create two subsets of the data (Data Set 1 & Data Set 2). These
participants had been diagnosed with a mental illness and were prescribed a medication regimen
for HIV treatment at the time of intake in a specialized clinic in Mexico City. Archival data was
obtained through a demographic intake questionnaire and the use of valid and reliable
instruments adapted for the specific population: State Impulsivity Scale (SIS) and the Beck
Depression Inventory (BDI). Data analysis included descriptive statistics related to population
demographics, bivariate correlations, and a sequential logistic regression based on existing
literature on HIV/AIDS, medication adherence, and a theoretical model of stress and coping.
Results of the analyses indicated that impulsivity was found to be predictive of medication
nonadherence in Data Set 1 and exposure to violence was found to be predictive of medication
nonadherence in Data Set 2. However, since both were not found to be significant across both
subsets of the data, the variables could not be considered to robustly predict medication
nonadherence in this study.
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CHAPTER 1
INTRODUCTION TO THE STUDY
This chapter introduces the study and provides an overview of the study’s purpose. The
problem statement which guides the purpose of the study leads into the research questions,
followed by a brief overview of the research design and proposed analysis. Finally, a list of
variables and corresponding operational definitions conclude this chapter. The goal of the
chapter is to provide an overview of the scope of the problem, the purpose and design of the
current study, as well as operational definitions of the variables and review of the terminology
relevant to field of HIV and AIDS research.
Problem Statement
Maximizing medication adherence is crucial for improving health outcomes in
individuals with HIV and AIDS and is a critical aspect in efforts aimed toward the prevention
and monitoring of HIV drug resistance (World Health Organization [WHO], 2017). However,
research has shown that patients who are prescribed antiretroviral medications do not always
adhere at optimal levels (Ingersoll, Dillingham, Reynolds, Hettema, Freeman, Hosseinbor, &
Winstead-Derlega, 2014). Physicians treating patients with HIV suggest 95%-100% adherence to
antiretroviral medication to hinder the replication of HIV in the bloodstream, strengthen immune
functioning, lower likelihood of transmission, and decrease the chances of developing drug
resistance (National Institutes of Health [NIH], 2017a; Smith, Rublein, Marcus, Brock, &
Chesney, 2003). As the level of adherence decreases, the likelihood of virologic failure
increases. Virologic failure occurs when medications used to treat HIV fail to suppress and
sustain a person’s viral load to less than 200 copies/mL (NIH, 2017b).Virologic failure and drug
resistance can develop when adherence is not at optimal levels, increasing the chances that an
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individual could develop and transmit new drug-resistant strains of the virus in which HIV
medications may no longer be effective. Adherence to medication is influenced by a variety of
factors including the medication regimen itself, the patient-provider relationship, and
psychosocial, behavioral, and structural barriers (NIH, 2017). For this reason, continued research
on the topic is vital to the understanding of the factors contributing to medication adherence in
diverse populations to improve interventions, integrative care, and health outcomes.
For this study, medication adherence was examined in a population of HIV-positive
individuals in Mexico City. While the prevalence of HIV and AIDS is lower in Mexico in
comparison to other Latin American nations, there has been an increase in the amount of
detected drug resistant strains of HIV in recent years signaling a significant concern for public
health and medical professionals. The clinic from which the data were derived is one of the
largest HIV-centered treatment facilities in Mexico and Latin America with a program targeting
specialized treatment of HIV and AIDS patients who have been diagnosed with mental health
disorders. Being that Mexico City is the largest metropolis in Latin America, it is an ideal setting
to gain an understanding of the multitude of dynamics impacting HIV and AIDS treatment,
specifically related to medication adherence. Typically thought of from a medical perspective,
medication adherence is a topic most often discussed by physicians. While it is essential for
physicians to be involved in the screening of medication adherence, it is also essential for the
involvement of other professionals, including counselors and related mental health specialists
who may be more attuned to psychosocial and mental health factors impacting the lives of
patients. As Western medicine continues to move toward an integrative care model, it is crucial
to create effective treatment models in HIV/AIDS-specialized clinics and treatment centers to
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foster interprofessional collaboration, streamlined communication and treatment for optimized
health outcomes.
Purpose of the Study
The purpose of this study was to examine the relationships among psychosocial factors,
immune functioning, and medication adherence in HIV-positive individuals. The archival data
set which was utilized has never been analyzed before, creating a unique opportunity to explore
phenomena occurring in this population. The researcher intended to investigate these
aforementioned relationships to cultivate new knowledge for the clinic in Mexico City and to
contribute to ongoing research regarding medication adherence in public health. Additionally, it
is the hope of both this researcher and the clinic staff that this study may highlight the need for
further research on this topic as well as targeted efforts for improving medication adherence.
Additionally, this study may emphasize the importance of enhanced screening for risk factors for
nonadherence and improved interventions for HIV patients using integrative care models where
collaboration across the health professions is the norm. Based on prior literature, the following
research questions guided this study:
1. What are the relationships between CD4 counts, violence, disclosure, and social support
in HIV-positive individuals?
2. To what extent do disclosure, social support, impulsivity, and exposure to violence
predict medication adherence in HIV-positive individuals after controlling for depression
and major stressors experienced within the past year?
Summary of Research Design
A nonexperimental, cross-sectional research design was utilized because it allowed
examination of data from a specific point in time. An archival data set that was developed
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between 2013-and-2016 from a specialized clinic in Mexico City was used because of the unique
opportunity to add to the literature information regarding research on HIV treatment and
medication adherence among persons from Latin American countries, specifically Mexico. This
addresses a gap in counseling literature which lacks in research focused on HIV treatment in
international settings. Previous studies on HIV-positive individuals focusing on adherence have
used a variety of research designs and analyses to study factors influencing medication
adherence and nonadherence among people living with HIV/AIDS. Studies reported in the
literature utilized bivariate and multivariate logistic regression models, however, lacked
sequential analyses to control for the influence of pre-existing psychological variables such as
depression and major stressors experienced within the past year (e.g. Chandwani et al., 2012;
Rotzinger et al., 2016; Weaver, Pane, Wandra, & Windiyaningsih, & Samaan, 2014). In the field
of HIV/AIDS research, contradictory literature regarding psychosocial phenomena is the norm,
requiring specific models to be tested within new populations in differing geographic regions,
cultures, and ethnic groups. The current data set has never been analyzed and will contribute to
the body of literature on people living with HIV/AIDS. To better understand the relevance of
psychosocial factors in the role of medication adherence in the population of HIV-positive
individuals in Mexico City, a regression analysis was most helpful since regression analyses
assist in studying the relationships between several predictor variables and an explicit outcome
(Heppner, Wampold, & Kivlighan, 2008). For this study, a sequential logistic regression design
was utilized in which the researcher specified the order of entry of the predictor variables based
on a theoretical rationale (Petrocelli, 2003; Tabachnick & Fidell, 2014). Due to information
about medication adherence largely being derived from self-report, nonadherent patients are
underrepresented creating an imbalance between adherent and nonadherent groups. The
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researcher first ran a logistic regression using the full sample; however, due to this imbalance,
two binary logistic regression analyses were conducted. Each analysis included the same group
of nonadherent individuals but included a random sample of patients from the adherent group in
order to provide an adequate representation of the population.
Operational Definitions of Variables
The effects of six predictor variables on a binary categorical outcome variable was
examined. The six predictor variables were disclosure, social support, impulsivity, exposure to
violence, stressors, and depression. The outcome variable was medication adherence.
Disclosure to family. Disclosure in this study is a nominal variable with four levels
defined by: a) whether or not the individual disclosed their HIV/AIDS status to family members,
and b) if yes, the reaction of the family members to their disclosure (support, indifference,
rejection). This information is collected as part of the initial evaluation at the clinic.
Social support. Social support in this study is a continuous variable. It is defined as the
number of close friends an individual has with whom they can share anything, including
HIV/AIDS-related information. This information is collected as part of the initial evaluation at
the clinic.
Impulsivity. Impulsivity is a continuous variable which is measured by the State
Impulsivity Scale. The scale is explained in detail in the instrumentation section of Chapter 3
(Iribarren, Jiménez-Giménez, García-de Cecilia, & Rubio-Valladolid, 2011).
Exposure to violence. Exposure to violence is a continuous variable. This variable
represents the number of different types of violence an individual has experienced throughout
their lifetime: psychological, economic, physical, sexual and is included as a self-reported
response on the initial evaluation at the clinic.
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Depression. Depression is a continuous variable. Depression is measured by an adapted
version of the BDI developed and validated in Mexico (Beck, Steer, & Brown, 1996).
Stressors. Stressors is a continuous variable. Stressors are self-reported and defined by
the amount of stressors, chosen from a predetermined list on the intake form, which a person has
experienced within the past year: death of a family member, divorce/separation of parents,
diagnosis of family member with serious chronic illness, legal problems, serious family fights,
change of job, moving (Holmes & Rahe, 1967).
HIV/AIDS Terminology
Important to the study is the understanding of several relevant terms relating to the study
and treatment of HIV and AIDS including the following (NIH, 2017b):
1. HIV: Human Immunodeficiency Virus. HIV takes over CD4 cells which are lymphocytes
or white blood cells, integral parts of the body’s immune system leading the body’s
defense against infections. HIV becomes part of the CD4 cells and forces the cell to
produce thousands of copies of the virus (NIH, 2017b).
2. AIDS: Acquired Immunodeficiency Syndrome. AIDS is the most advanced stage of HIV
infection resulting from prolonged depletion of CD4 cells which have been attacked by
HIV. A diagnosis of AIDS occurs when a person with HIV has a CD4 count less than 200
cells/mm³ (NIH, 2017b).
3. Viral Load: The amount of HIV in a sample of blood. A goal of antiretroviral therapy
(ART) is to suppress viral load to an undetectable level (NIH, 2017b).
4. CD4: The CD4 count is the most important laboratory guide of immune functioning and
the strongest predictor of HIV progression. The CD4 count is one of the factors used to
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gauge an individual’s response to ART and also signals when a patient should start ART
(NIH, 2017b).
5. Antiretroviral Medication/Therapy (ART): The daily use of a combination of HIV
medicines to treat HIV infection (NIH, 2017b).
6. Medication Adherence: The act of taking ART as agreed upon by patient and
prescribing physician (NIH, 2017b).
7. Drug Resistance: Drug resistance occurs when mutations of HIV develop while a person
is taking HIV medications. HIV medications previously effective for a person are no
longer effective. An individual can also be infected by a drug-resistant strain of HIV
(NIH, 2017b).
8. Virologic Failure: Virologic failure occurs when ART fails to suppress and sustain a
person’s viral load to less than 200 copies/mL which can result from drug resistance,
drug toxicity, and poor treatment adherence (NIH, 2017b).
9. Detectable/Undetectable: An individual is said to be undetectable when viral load is too
low to be measured. This is usually considered to be a viral load of below 50 (NIH,
2017b).
10. MSM: Men who have sex with men (NIH, 2017b).
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CHAPTER 2
REVIEW OF THE LITERATURE
This chapter begins with a review of the historical context of HIV and AIDS in the
United States, Latin America, and Mexico. Included in this historical overview, is a definition of
HIV/AIDS and relevant biological processes to provide a foundation for the discussion of
psychosocial, behavioral, and demographic factors linked to HIV/AIDS health outcomes and
medication adherence. A theoretical framework was used to conceptualize these factors and
provide empirical support for the current study. Additionally, the researcher discussed the
importance of this study and how it is intended to support the need for integrative care in
HIV/AIDS treatment.
Overview of HIV/AIDS: Epidemiology and Historical Context
Of all the global health crises that have occurred, few have had as devastating an impact
in recent times as HIV/AIDS. Distinctively, it is also unequally distributed across the world’s
population (Lashley, 2000). Nearly four decades ago, the first indication of a bizarre
immunodeficiency, uncommon opportunistic infections, and Kaposi’s sarcoma were first noticed
in young gay men in the United States (Lashley, 2000). These observations signaled the start of
one of the most medically, emotionally, and politically alarming epidemics of the century. While
this is the case, we have been able to learn and understand more about the human
immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) in a
shorter period than perhaps any disease in history. Much of what has been discovered has even
been applied to research on other diseases such as cancer. During the beginning of this health
crisis, emphasis was placed on identification of at-risk populations but has shifted in recent years
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to focus on understanding behaviors which put individuals at risk of transmitting or contracting
the virus. (Lashley, 2000).
The Human Immunodeficiency Virus (HIV) is a virus which is spread through bodily
fluids and attacks the body’s immune system by destroying CD4 cells, or T cells. This damage to
the immune system decreases the body’s ability to fight off infections and disease. If left
untreated, HIV can continue to reduce the count of CD4 cells in the body making individuals
who have been infected more susceptible to opportunistic infections or cancers (U.S. Department
of Health & Human Services, 2016). HIV continues to be a major issue in global public health
with an estimated 36.7 million people living with the virus (Joint United Nations Programme on
HIV/AIDS [UNAIDS], 2014). While the majority of HIV cases have been diagnosed in subSaharan Africa, societies worldwide are affected by the virus.
AIDS is defined generally as a set of conditions that are indicative of severe
immunosuppressive functioning related to an HIV infection. A decrease in CD4+ T lymphocytes
below 500/mm3 reflects this severe immunosuppression (Lashley, 2000). Two different types of
human immunodeficiency virus (HIV), HIV-1 and HIV-2, affect humans. Substantial evidence
exists supporting the hypothesis that HIV-1 in humans resulted from cross-species transmission
of an agent in chimpanzees, and HIV-2 from cross-species transmission from sooty mangabeys
(DeCock, 2008). Three groups of HIV-1 have been recognized: groups M, N, and O. The
majority of the world’s infections are with the HIV-1 group M viruses, of which some 10
different subtypes exist. In the United States and the Americas, Europe, and Australia, subtype B
predominates. Subtype C has swiftly swept throughout much of India and Southern Africa.
Generally, when people discuss HIV, it is implicit that they are speaking of HIV-1. Groups O
and N viruses are effectively restricted to Central Africa (Worobey, 2008).
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HIV-2 is less transmissible than HIV-1, conceivably due to the lower viral load
associated with it throughout much of its natural history. HIV-2 is principally restricted to West
Africa, but has been documented in individual cases across all continents. Countries with larger
West African immigrant populations such as France, Portugal, and former Portuguese colonies
have also had cases of HIV-2 (Worobey, 2008). Little evidence exists to suggest that
transmissibility differs among the subtypes of HIV-1. However, the subtypes remain of interest
to researchers due to the insight provided by their distribution which helps in the understanding
of the spread of the HIV epidemic (Kull, 2010).
History of HIV/AIDS in the United States
Since the first documented AIDS-related deaths in 1981, HIV has grown into a pandemic
which has deeply affected individuals, relationships, communities, politics, and the globe. In
addition to being a serious disease, HIV generates problems in social, economic, and political
domains which underscore inequalities on a global scale. Additionally, HIV/AIDS has brought
attention to homophobia, poverty, racism, the oppression of women, and health care disparities
(Kamya, 2010; Kull, 2010).
In 1981, the Centers for Disease Control and Prevention (CDC) began investigations of
an emerging health crisis which seemed to be affecting men who identified as gay. In the next
year, the CDC had documented cases among heterosexuals, intravenous drug users, babies,
Haitians, and individuals with hemophilia (Centers for Disease Control and Prevention [CDC],
1981a; CDC, 1981b). While the illness was named acquired immune deficiency syndrome and
challenged the label of “gay cancer”, without a clear understanding of what caused the disease,
many continued to view AIDS as the consequence of the immoral behavior (Harris et al., 1983;
Kull, 2010; Levine, Nardi, & Gagnon, 1997). Gay communities in urban centers responded by
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organizing political and community advocacy groups to uncover inherent disparities in the health
care system of the United States. Fear later became widespread as public figures became affected
and entered the spotlight. In the 1990s, while HIV/AIDS infections and deaths peaked, the
Clinton administration made noteworthy advances in HIV/AIDS funding and developed the
Office of AIDS Research which was intended to oversee the allocation of research funds (Kull,
2010).
Current State of HIV/AIDS in the United States
At the end of 2014, it was estimated that 1.1 million people ages 13 and older were living
with HIV (CDC, 2015). This includes an estimated 166,000 individuals whose infections had not
yet been diagnosed. The estimated number of new infections at this time was 37,600. Estimated
annual HIV infections in the United States declined by 18% from 2008 to 2014 (CDC, 2015). In
2015, the number of new HIV diagnoses in the United States was 39,513. The majority, 31,991,
of these diagnoses were of adult and adolescent males. The most affected racial group with
17,670 of the new diagnoses of infection in 2015 was African American (CDC, 2015). New
diagnoses of Latinos comprised 9,290 while new diagnoses of Whites comprised 10,509. To this
day, the leading cause of transmission remains male-to-male sexual contact comprising 26,375 of
the new diagnoses in 2015. At the end of 2014, there were 955,081 people living with diagnosed
HIV infections in the United States (CDC, 2015).
History of HIV/AIDS in Latin America
HIV emerged in Latin America during an era when anti-Americanism sentiments were
rampant due to President Ronald Reagan’s policies in Central America during the 1980s
(Smallman, 2007). Subsequently, AIDS transformed into a compelling symbol of the menacing
threat of American culture. HIV became symbolic of the perceived social collapse, degenerate
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morality, and urban decay of American society. Media coverage in Latin America, influenced by
this perspective, focused on reassuring the public by spreading the message that HIV/AIDS
would not affect Latin America the way it had in the United States (Smallman, 2007). Hysteria
ensued in Latin America once the first cases of HIV were confirmed across the region in the
early 1980s. Even though the disease was initially isolated from the general population,
impacting men living in the cities, the number of AIDS cases increased exponentially across
Latin America with a rapid increase in the number of women diagnosed (Smallman, 2007).
Current State of HIV/AIDS in Latin America
In Latin America, where HIV prevalence is relatively lower, the epidemic continues to be
stable with a large amount of cases being reported in countries with greater populations. In 2013,
approximately 1.6 million people were living with HIV in Latin America with around 94,000
new diagnoses and 47,000 deaths directly attributed to HIV/AIDS and its affects (UNAIDS,
2014). Populations most affected are men who have sex with men, transgender women, sex
workers, and people who inject drugs. While there has been an increase in awareness of the
importance for increased education, testing, and funding for programs, it is estimated that 50% of
people who are HIV+ do not know their status. This is a serious issue since lack of awareness of
one’s status can lead to late diagnosis when CD4 counts are already under 200 cells/mm3
indicating a stage 3 infection, or AIDS. Fortunately, antiretroviral treatment (ART) is highly
accessible across Latin American nations with nearly 75% of individuals in need of the treatment
receiving it (UNAIDS, 2014; Avila-Rios et al., 2011). Programs in Latin America which have
aimed to increase knowledge and change attitudes and behaviors associated with HIV risk have
been shown to reduce discrimination and stigma which have historically been barriers to
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treatment across the region. According to these statistics from UNAIDS (2014), three quarters of
people living with HIV in this region are in Brazil, Colombia, Venezuela, and Mexico.
History of HIV/AIDS in Mexico
Early cases of AIDS were concentrated among middle- to upper-class gay men in the
urban centers when the illness first appeared in Mexico in 1983. The risk posed by HIV was
initially ignored as it was in the United States since the gay community was the primary victim
(Frasca, 2005; Smallman, 2007). The threat of the illness was largely downplayed due to its
absence among the general population. In the general population, worry did not exist that
HIV/AIDS could be transmitted through unprotected heterosexual sex. However, terror spread
with the possibility of catching the disease through casual contact with homosexuals. These
sentiments led to increasing discrimination against homosexuals across the nation with violent
messages appearing in public urging for the killing of homosexuals. In 1986, CONASIDA, a
national AIDS council, was created which was followed by the establishment of a national
surveillance system for HIV/AIDS to monitor the transmission of the illness after it had begun to
appear in other populations (Stover & Bravo, 1991; Castro & Leyva, 2002). In 1987 and 1988
the government launched a significant education endeavor which aimed its efforts at providing
condoms to the public. In the 1990s, the government also took steps to provide antiretroviral
drugs to the general population. While at first only covered by social security and other state
health plans, in 2003, President Vicente Fox vowed to make these medications available to all
Mexicans who were HIV-positive (Carrillo, 2002; d’Adesky, 2004).
Current State of HIV/AIDS in Mexico
In Mexico, HIV/AIDS remains an urgent health matter which requires the
interdisciplinary collaboration from a vast array of organizations and other divisions of the
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public sector to effectively respond to its challenges. According to the Secretary of Health and
the National Center for Prevention and Control of HIV and AIDS in Mexico, the HIV epidemic
in Mexico is concentrated as it has not been established in the general population (Centro
Nacional para la Prevencion y el Control del VIH y el sida [CENSIDA], 2015).. Currently, the
prevalence in the general population is estimated to be .23% (UNAIDS, 2014). The epidemic
remains specific to populations such as men who have sex with men (MSM, 17.3%), male sex
workers (MSW, 24.1%), transgender women (TS, 15.5%), and people who inject drugs (IDU,
2.5%) (Centro Nacional para la Prevencion y el Control del VIH y el sida [CENSIDA], 2015). It
is estimated that the prevalence of HIV infection in individuals between 15 and 49 years old is
0.2% - 0.3% and that there are up to 270,000 people with the virus living in Mexico. During the
period 2010-2013, new cases of HIV and AIDS have increased, which seems to be a result of an
increase in screening efforts rather than an increase in the spread of the virus. While HIV/AIDS
has been reported in all states of Mexico, the majority of cases are concentrated in the Federal
District and the State of Mexico. As in the United States, women have become the group with
the highest prevalence increase over the past two decades and are more vulnerable to infection
due to systemic problems regarding access to education, employment, and health services
(CENSIDA, 2015).
In Mexico City, the first cases of HIV/AIDS in Mexico were identified in Mexico City in
1983. By 2012, around 40,000 people were living with HIV in Mexico City. This number
represents 17% of national cases, making Mexico City the region with the highest prevalence of
HIV in the country (Clinica Especializada Condesa, 2013). In a specialized clinic in the heart of
Mexico City, a monthly average of more than 1,500 people are received in the detection and
counseling centers of the clinic. Of the nearly 20,000 people who had presented voluntarily to
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the clinic for HIV screenings in 2013, approximately 14% were HIV positive. Since 2008, there
has been an increase of 569% in the detection services of the clinic (Clinica Condesa
Especializada, 2013). In 2013 alone, each HIV counselor at the clinic served over 3,000
individuals. Additionally, this clinic is the first and only clinic in Mexico which caters to the
healthcare needs of transgender-identified individuals and has offered free specialized care
services to over 725 transgender persons. Monthly, an estimated 18 transgender-identified
individuals arrive as new patients of which more than 30% are HIV-positive. In 2013, a total of
935 people were victims of sexual violence, a vast majority (93%) were women with a mean age
of 23 years (Clinica Condesa Especializada, 2013).
Links between HIV, Psychosocial Stressors, and Wellbeing
Psychiatric morbidity was detected early in the HIV epidemic. As such, HIV has long
been associated with psychological distress including anxiety, depression, and other general
negative mental health outcomes as it is a disease which significantly impacts all aspects of
wellbeing (Folkman, 1993; Stewart et al., 2012; Choi et al., 2016). A study conducted in the
United States in the 90s showed that 48% of adults receiving care for HIV showed signs of at
least one psychiatric disorder on screenings within the previous year (Bing et al., 2001). This
study included 2,864 who were administered a screening assessment for multiple psychiatric
disorders including major depression, dysthymia, generalized anxiety disorder, and panic
disorder. Researchers in the Netherlands studied the relationships between coping styles, goal
disturbances, and psychological distress in HIV-positive individuals. In a sample of 43
participants from ages 23-63 who were at different stages of disease progression, the researchers
found that disturbances of daily events, or goal disturbance, was directly related to higher levels
of psychological distress. It was suggested from this study that these daily disturbances could
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result from HIV and associated symptoms as well as the medical regimen or associated sideeffects (Van Der Veek, Kraaij, Kopeen, Garnefski, & Joekes, 2007). A more recent study
conducted in 2013 used a community sample of 197 people living with HIV/AIDS to examine
the impacts of societal stigma and internalized stigma on psychological wellbeing. Researchers
concluded that stigma associated with HIV plays a central role in the development of depression
and anxiety, especially in individuals who display pessimistic coping styles (Herek, Saha, &
Burack, 2013). In 2014, a study conducted using a representative community sample in rural
South Carolina assessed perceived stress, mood profile, and symptom-related distress to better
understand the association between symptom distress and psychological factors among HIVpositive persons. Participants were 18 years of age or older and were not taking medications to
treat depression or anxiety at the time of the study. The results showed that the strongest
correlations were between fatigue and symptom frequency and fatigue and symptom distress
(Jaggers, Dudgeon, Burgess, Phillips, Blair, & Hand, 2014). These findings are important in their
contribution to the literature since previous research has shown that fatigue is one of the most
common symptoms reported by persons living with HIV/AIDS. Several studies in the early
2000s support these findings identifying strong correlations between fatigue and multiple
measures of psychological distress and psychological distress, decrease in routine activities, and
physical functioning due to fatigue (Norval, 2004; Phillips et al., 2004; Henderson, Safa,
Easterbrook, & Hotopf, 2005; Hand, Phillips, & Dudgeon, 2006). Additionally, psychological
distress has been detected in higher levels in persons living with HIV who report experiencing
fatigue (Breitbart, McDonald, Rosenfeld, Monkman, & Passik, 1998). These combined results
show that there is a long-known history of the correlation between psychiatric distress and
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HIV/AIDS diagnoses with strong support for the consequences of long-term distress leading to
negative health behaviors and decreased quality of life.
Psychological stress, dejection, and distress are pervasive with chronic illness. Common
sources of psychological distress in individuals with chronic illness are the ambiguity regarding
one’s future state of health, instability of symptoms or physical discomfort, and the impact on the
individual’s family and relationships (Holder-Perkins & Akman, 2006). Studies of individuals
diagnosed with severe illness have labeled several key themes for preserving emotional stability
including a search for meaning, attempts to gain control over illness, and attempts to enhance
self-esteem (Holder-Perkins & Akman, 2006).
The immediate psychological impact following an HIV diagnosis is commonly one of
acute distress manifested as depressed mood, anger, shock, anxiety, tension, perceived stress, and
overwhelming intrusive thoughts. The prevalence of these symptoms has not yet been
determined. While these symptoms are typically mild, they can be severe and even crippling to
the degree that they may meet the criteria for a diagnosable psychiatric disorder (Holder-Perkins
& Akman, 2006).
Depression and HIV
Depression constitutes the second most frequently observed illness worldwide. In the
United States, depression is observed in about 6.7% of the population (National Institute of
Mental Health, 2017). Among chronically ill persons in the United States, the rate of depression
is higher at 9.5% with patients who suffer from HIV infection or AIDS experiencing a rate of
depression which is significantly higher, ranging from 20-40% (U.S. Department of Veterans
Affairs, 2018). Additionally, suicide ideation tends to be present among two thirds of patients
who are depressed and the rate of suicide among depressed patients is 10-15% (Ruiz, 2006).
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Several factors that put patients with HIV/AIDS at higher risk for depression are those
with exposure to chronic stress, inadequate social support, and passive coping styles. Other
factors which contribute to higher risk of developing depression are nondisclosure of HIV status,
multiple losses, advanced illness, alcoholism, substance use, female gender, and personal or
family history of suicide attempts, mood disorders, and anxiety disorders (Ruiz, 2006). The most
common complications of chronic medical illness involve depressive symptoms. Studies have
shown that depression has a damaging effect on patients’ quality of life, adherence to treatment,
and treatment outcomes (Treisman & Angelino, 2004). Despite compelling research, depressive
conditions remain underrecognized, underdiagnosed, and undertreated in medical clinics,
especially in treatment centers focused on HIV/AIDS. Depression should be a major concern for
HIV/AIDS researchers and treatment providers as it can impact patient attitudes toward
treatment. Individuals with depression often care less about their own safety, act impulsively,
and have perpetual feelings of hopelessness (Treisman & Angelino, 2004).
Studies have shown an increased prevalence of HIV among individuals who have mental
health problems and an elevated prevalence of depression and other mental health conditions
across individuals who are HIV seropositive (Anderson & Weatherburn, 2004; Bing et al., 2001;
WHO, 2008). Researchers exploring the association between disease progression and depression
in both men and women found that individuals with HIV who exhibited depressive symptoms
were nearly 2 times more at risk of mortality than individuals who did not (Ickovics et al., 2001;
Mayne, Vittinghoff, Chesney, Barrett, & Coates, 1996). While an abundance of research has
established the connection between physical illness and depression, it has been challenging to
establish the causal pathway between the two. Depression can affect immune function; however,
it may also be the outcome of disease progression or negative life events (Pence et al., 2006).
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Adherence and HIV
Adherence to medication can be defined as the extent to which a person’s behavior
matches the health care regimen prescribed by a medical professional. Importantly, this treatment
regimen should be agreed upon by the healthcare professional and the patient. Adherence
involves taking medication correctly, at the right time, with the proper frequency, and at the
accurate dosage (Brown & Bussell, 2011; Cramer et al., 2008). Medication adherence is vital for
improving health outcomes with physicians emphasizing 80%-95% adherence for optimal
trajectory of health outcomes (Osterberg & Blaschke, 2005). However, physicians researching
and treating HIV patients suggest 95%-100% adherence to antiretroviral medication to impede
the replication of HIV in the bloodstream, strengthen immune functioning, lower likelihood of
transmission, and decrease the chances of developing drug resistance (National Institutes of
Health, 2017; Smith, Rublein, Marcus, Brock, & Chesney, 2003). While many HIV regimens
currently include a combination of medications to effectively treat individuals, two main types of
antiretroviral medications used are protease inhibitors and non-nucleoside reverse transcriptase
inhibitors. Research has shown that in samples of HIV-positive individuals adhering 90% of the
time to each of these classes of drugs, 55% of patients taking protease inhibitors and less than
10% taking non-nucleoside reverse transcriptase inhibitors experienced virologic failure
(Paterson et al., 2000; Viswanathan, et al., 2016). As the level of adherence decreases, the
likelihood of virologic failure will increase. Virologic failure is defined as a level of greater than
400 copies/mL of HIV in the bloodstream than the last clinic visit. Virologic failure and drug
resistance can develop when adherence is not at optimal levels, increasing the chances that an
individual could develop and transmit new drug-resistant strains of the virus in which HIV
medications may no longer be effective (National Institutes of Health, 2017b). Factors to
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consider which may impact adherence in an individual are side effects, high cost of treatment,
lack of access to treatment, poor communication between provider and patient, unstable living
situation, alcohol or drug use, fear of disclosure, and illness or depression (National Institutes of
Health, 2017b; Cutler & Everrett, 2010; Simpson, 2006). In research conducted examining
correlations between race and medication adherence, researchers found that Hispanics and
African Americans have lower medication adherence rates in comparison with Caucasians
(Manias & Williams, 2010; Simpson, 2006).
Depression, Adherence, and HIV
Depression and psychological distress have been well-documented in research as
contributing factors to negative health outcomes and poor adherence to medical treatments
(DiMatteo et al., 2000; Manning & Wells, K. B., 1992). Grenard et al. (2011) conducted a metaanalysis of 31 studies including over 18,000 participants to explore the relationship between
depression and medication adherence in the treatment of chronic illnesses in the United States.
Depressed patients were found to be 1.76 times more likely to be nonadherent to treatment
regimens than their non-depressed counterparts. In a review of the literature regarding Latino
HIV-positive men who have sex with men (MSM), increased levels of depression were
associated with increased frequency of high-risk sexual behaviors, implicating increased risk for
transmission of HIV, especially if those individuals were nonadherent (Gonzales, Hendriksen,
Collins, Durán, & Safren, 2009). In the United States, where Latinos are less likely to seek help
and receive proper treatment for mental illness, including depression, the risk for nonadherence
is increased (Gonzales, Hendriksen, Collins, Durán, & Safren, 2009). Numerous studies focusing
on HIV-positive men and adherence behaviors have supported the relationship between
depression and nonadherence to treatment underscoring the importance for effective and
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informed clinical practice, preventive measures, and intervention (Blashill, Perry, & Safren,
2011; Gonzalez et al., 2004).
In Mexico, researchers have found depression to be prevalent among persons living with
HIV at similar rates to studies conducted in the United States (Caballero-Suarez, RodriguezEstrada, Candela-Iglesias, and Reyes-Teran, 2017). In northern Mexico, a study was conducted
with 64 participants where researchers examined the relationships between stress levels,
depression, and adherence to medication regimen. The results of the study showed that high
levels of stress and depression tend to occur simultaneously and contribute to poor adherence to
medical treatment (Piña Lopez, Dávila Tapia, Sánchez-Sosa, Togawa, & Cázares Robles, 2008).
This has strong implications for assessment, early intervention and treatment, and maintenance
for HIV/AIDS patients as poor adherence to antiretroviral medication may result in proliferation
of HIV in the body as well as drug resistance. Pérez-Salgado, Compean-Dardón, & OrtizHernández (2016), obtained a sample of persons living with HIV from various clinics in Mexico
to study the relationship between food insecurity and adherence to HIV medications. From the
sample in Mexico City, it was noted that psychological distress best explained the relationship
between food insecurity and medication adherence. While food insecurity is associated with poor
mental health and poor adherence to treatment, it is also important to note that poor mental
health status has generally been associated with nonadherence. That is to say, deficient
psychological distress is another potential mechanism by which food insecurity would be
associated with nonadherence to medication.
Models of Stress and Coping
Helpful to understanding the impact of HIV/AIDS on an individual are two models to
conceptualize responses to stressors: the biopsychosocial/spiritual model and the Transactional
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Model of Stress and Coping. The first acknowledges that all persons have many aspects of life
which interact with each other while the second discusses stressors, reactions to stressors, and the
consequences of these reactions.
Biopsychosocial Model
Historically, Western society has viewed biological, psychological, social, and spiritual
domains of an individual separately and has viewed health care as medical care with an emphasis
on biomedical responses. In this model, these domains (biomedical, psychological, social, and
spiritual) are distinct in order to distinguish components relevant to assessment and intervention
planning, however, it is important to emphasize that these components interplay and impact one
another (Engel, 1980; Winiarski, 1997).
In the case of an individual who has been diagnosed with HIV, an individual is typically
faced with a series of laboratory tests, appointments with medical providers, and prescriptions
for medications. While important, the individual’s psychological response, support system, and
spiritual reaction also require attention. Medical assessment, intervention, and treatment
practices of HIV are the norm in many clinics and agencies in developed nations, while adequate
attention to psychological, social, and spiritual issues often neglected. For psychological
functioning, it is important to note the client’s pre-HIV psychological status and how it has
changed due to the diagnosis of HIV. Individual emotional response, acute psychological
symptoms, history of mental illness or substance use, and sexual functioning should also be key
components of a psychological assessment. Regarding social issues, a client’s cultural
background should be better understood to provide context for the individual experience of
diagnosis, living with HIV, and one’s psychosocial reaction to living with HIV. Socioeconomic
status may also provide relevant information as to an individual’s vulnerability to isms such as
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racism, classism, heterosexism, and sexism. Other social factors to consider are education level,
with whom with client lives, family response to diagnosis if HIV status was disclosed, family
structure, and relationship status (Straub, 2011).
The Transactional Model of Stress and Coping
The Transactional Model of Stress and Coping developed by Lazarus and Folkman
(1984) provides a framework through which this proposed study can be viewed. The model, as
shown in Figure 1 below (Ross & Altmaier, 1994) provides a foundation for conceptualizing
stressors and how the reactions to stressors impact the trajectory and outcomes of chronic illness
as it examines stress and the interaction between people and their environment. These
transactions, as they are called, between the person and environment, depend on the impact of
the stressor and are mediated by the individual’s appraisal of the stressor. This is what is termed
as primary appraisal or a person’s perception of the event.
Additionally, the model takes into consideration the available societal resources. This
secondary appraisal is a judgment of one’s own internal resources or coping strategies as well as
external resources and options. Stress, then, is defined as these aforementioned transactions
which are perceived to exceed the internal and external resources of an individual thereby
causing immense strain on one’s wellbeing (Lazarus & Folkman, 1984). Together, this set of
appraisals assists an individual in understanding what course of action, if any, can be taken to
address a stressful situation. These efforts to cope with the stress lead to outcomes of the coping
process which have an impact on health behaviors, wellbeing, and overall functioning (Cohen,
1984). In addition to describing cognitive appraisal, Lazarus (1999) discusses the significance of
emotions and impacts on the coping process.
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According to Lazarus (1999), these two forms of appraisal function interdependently
although he describes them as two separate and equally important mechanisms. Primary
appraisal relates to “values, goal commitments, beliefs about self and world, and situational
intentions” (p. 73). In this mode of appraisal, goal commitments are seen as having the greatest
influence since it relates to the way an individual will work toward a goal. If an individual is
without goal commitment, stress and associated emotions will not occur since there is a lack of
investment in one’s wellbeing directly related to a specific transaction. When goal commitments
do exist, the person places more value in a transactional situation which leads to a disturbance in
the usual daily occurrences due to a sense of potential harm (damage already occurred) or threat
(possibility of damage occurring in the future).
Secondary appraisal largely involves a cognitive process whereby the individual
evaluates a course of action about a transaction, or stressful person-environment interaction. This
evaluation occurs simultaneously when a person perceives harm or threat through primary
appraisal. While this secondary appraisal is not in actuality a form of coping it does have
implications for the effectiveness of one’s ability to cope with the given situation. The model
postulates that the more confidence one has about one’s ability to address obstacles and
adversities, the more likely the individual will experience challenge rather than threat. It is
obvious that situational perceptions and resources differ significantly among people, so the
experiences of a specific transaction largely depend on the individual and context (Lazarus,
1999).
Concerning emotional appraisal, the structure that applies to cognitive appraisal also
applies. The three components of primary appraisal of emotion consist of goal relevance, goal
congruence, and type of ego involvement. Emotions are then seen to be the product of the goal or
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lack of goal, whether the conditions of a transaction are favorable to the individual or not, and
the self-esteem, morals, and ideals of a person. Secondary appraisal of emotion consists of
coping potential and future expectations of a transaction (Lazarus, 1999).
Application of Stress and Coping Models
More recently, literature has begun to apply the framework of stress and coping models
to HIV research and has shifted focus to the role of stress and coping in both the physical and
mental health of HIV+ patients. One research investigation which analyzed the appraisal of
meaning attributed to an HIV diagnosis indicated that a positive personal meaning contributed to
adaptation to illness. This finding highlights the importance of consideration of psychological
wellbeing in the impact of HIV on the individual and supports that further research is needed in
this area to encourage the development of clinical mental health interventions aimed at reducing
negative effects of HIV-related stress (Farber, Lamis, Shahane, & Campos, 2014). In a study
conducted by Varni, Miller, McCuin, & Solomon (2012) it was found that individuals who
reported higher perceptions of stigma associated with their positive HIV diagnosis were more
likely to experience depression and anxiety as well as show evidence of avoidance and
disengagement styles of coping. In addition to these findings, this study also found that
individuals who perceived stigma also reported lower self-esteem. As the Transactional Model of
Stress and Coping suggests, it is imperative to consider both internal and external resources that
an individual perceives as available for coping. A study conducted by Chaudoir et al., (2012), for
example, found a relationship between spirituality and mental health of HIV+ patients in which a
strong sense of spirituality mediated the effect of stigma on distressing mental health symptoms.
While the links between stress and immune system functioning is complex, it is
undeniable that stress and other psychosocial factors impact immune function, including CD4
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levels in the blood. Even though the impact of stress is dependent upon the extent and force of
the stressor, the influence of chronic stress is long-term and enduring (Aldwin, 2007). In research
that studied the effects of stress on exposure to a virus, participants who reported chronic
interpersonal stress were more likely to develop clinical symptoms of the virus (Cohen, Tyrrell,
& Smith, 1991). Additional research on the healing of wounds has shown that participants who
experience greater levels of stress take longer to heal, likely due to lower levels of proteins
(cytokines) in the immune system caused by the stress which help to regulate inflammation and
healing (Kiecolt-Glaser, Page, Marucha, MacCallum, & Glaser, 1998). Furthermore, in addition
to mental health issues, immense stress experienced by an individual has been associated with
poor ART adherence which can lead to decreases in the CD4 count allowing for the proliferation
of HIV and even to drug resistance (Brinkley-Rubinstein, Chadwick, & Graci, 2013). Drug
resistance is of a major concern in Mexico, specifically, which has been a country of focus since
there has been an increase in patients displaying resistance to ART over the past few years
(Avila-Rios et al., 2011). The findings reported in the current literature on mental health and HIV
support the need for further research on the impact of social factors and mental health support on
the physical and mental health of HIV positive individuals. While there are many factors
influencing the lives of those affected by HIV, it is essential to gain a better understanding of the
array of stressors impacting this population to help professionals, and healthcare and government
organizations engage in the development of better education, programs, and clinical
interventions.
Social Support and Disclosure of HIV-positive Status
Social support has long been explored as a key component in health outcomes for
individuals with chronic illness. For individuals with HIV/AIDS, disclosure of one’s status is a

27
unique process complexly connected to social support and influenced by factors such as race,
society, perception of stigma, family, children, sex partners, and mental health (Rotzinger et al.,
2016). Chaudoir, Fisher, & Simoni (2011) reviewed literature on disclosure and its relationship
to social support, collaborating to establish a model which addresses the gaps in research on this
topic. Their Disclosure Processes Model aims to provide a framework to conceptualize the
process of disclosure for people living with HIV/AIDS. These researchers emphasize that
previously developed models have focused on the identification of factors leading to disclosure
such as disease progression, perceived consequences, and levels of relationship intimacy (Bairan
et al., 2007; Serovich, 2001; Serovich, Lim, & Mason, 2008) rather than the outcomes of
disclosure. The creators of the newer processes model argue that disclosure has implications for
both individual health and public health by having positive influences on overall health and
health behaviors. For example, individuals living with HIV/AIDS might attain greater social
support after disclosure encouraging openness about status and a change in behaviors and
perceptions impacting one’s health (Kalichman, DiMarco, Austin, Luke, & Difonzo, 2003).
Individuals may disclose their HIV-positive status to strengthen their relationships and to gain
social support from others, however, individuals may also avoid disclosure of their positive
status due to fear conflict and social rejection (Chaudoir, Fisher, & Simoni, 2011). Disclosure
has the potential to impact health outcomes as it can result in more social support, the mitigation
of negative psychological effects of suppression, and overall improved psychological wellbeing
(Strachan, Bennett, Russo, & Roy-Byrne, 2007). In a study conducted by Hays, McKusick,
Pollack, & Hilliard (1993), researchers found that HIV-positive MSM who disclosed their status
to their supports reported lower depression at a one-year follow-up. Strachan et al., (2007)
conducted a longitudinal study in which they found increased improved immune functioning
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predicted by disclosure of HIV status among a group of HIV-positive men and women in the
United States. This research was supported by previous research conducted by Sherman,
Bonanno, Wiener, & Battles (2000) which found increases in immune functioning among
children who disclosed their HIV status to at least one friend after a one-year follow-up in
comparison to children who had not disclosed their HIV-positive status. However, research
regarding disclosure and social support have been contradictory and inconsistent, especially in
regards to adherence to antiretroviral medications for HIV. According to the Disclosure
Processes Model, adherence to HIV medications can be facilitated by disclosure in that
disclosure provides access to social support and allows for individuals to take their medication
publicly, or at the very least in front of their supports to whom they have disclosed. Other
research has shown the opposite, specifically that disclosure has no association with adherence or
may actually lead to nonadherence. People living with HIV/AIDS often experience stigma
surrounding their diagnosis which may lead to psychological distress and chronic anxiety,
ultimately hindering adherence to antiretroviral medications (Guimarães et al., 2008; Sherr et al.,
2008). Waddell & Messeri (2006) found that while social support may in fact predict medication
adherence, social support only seems to matter when individuals have disclosed. Researchers
have had difficulty establishing the connections between social support, disclosure, and
medication adherence due to these inconsistencies but also due to the complex relationships
existing between these mechanisms and the probability that these relationships are mediated by
other psychological factors (Huynh, Kinsler, Cunningham, & Sayles, 2013; Waddell & Messeri,
2006).
In a cross-sectional study conducted in Mexico, 172 participants living with HIV/AIDS
were involved in a study examining antiretroviral adherence behaviors and the relationship to
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psychological and social variables (Ybarra Sagarduy, Piña Lopez, González Ramírez, & Fierros
Dávila, 2017). Among these 172 participants, 141 were 100% adherent to their treatment
regimens. The researchers used several measures including the Psychological Variables and
Adherence Behaviors Questionnaire (VPAD-24), the Stress-Related Situations Scale (SVE-12),
the Zung Depression Scale, and the Duke-UNC Functional Social Support Questionnaire, three
of which were adapted and validated in Mexico. Using structural equation modeling, the
researchers found a relationship between personality and medication adherence behaviors.
However, despite low levels of depression and high levels of perceived social support reported
among participants, no significance was determined in any of the structural models in this study
(Ybarra Sagarduy, Piña Lopez, González Ramírez, & Fierros Dávila, 2017). The positive
behaviors associated with personality, however, were found to have a direct, significant effect on
immune functioning and viral load.
Interpersonal Violence
Interpersonal violence is a broad term which includes child abuse, intimate partner
violence, hate crimes, and sexual assault and rape by a partner or non-partner. Interpersonal
violence has strong implications for health outcomes and health-related behaviors (Blashill et al.,
2011). Interpersonal violence has been associated with increased mental health issues including
PTSD and depression, chronic pain, and increased utilization of healthcare resources. Several
studies have been conducted to explore the links between medication adherence in exposure to
interpersonal violence. In a study conducted by Ramachandran, Yonas, Silvestre, and Burke
(2010), 73% of individuals in a sample of 56 diagnosed with HIV infection reported a history of
interpersonal violence, specifically intimate partner violence. Researchers found higher levels of
medication nonadherence among the 73% with exposure to violence during their lifetime. In
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another study conducted in 2010, researchers investigated the impact of intimate partner violence
on adherence to antiretroviral medication. Researchers obtained a sample of 190 participants
who were prescribed a medication regimen for HIV (Lopez, Jones, Villar-Loubet, Arheart, &
Weiss, 2010). It was found that a history of experiencing intimate partner violence was a
significant predictor of medication nonadherence for women but not men. Researchers found a
significant relationship, however, between negative coping strategies and poor adherence
behaviors among men. In a study where researchers tested a path model for nonadherence,
researchers found that interpersonal violence was correlated with poor medication adherence in
addition to poor quality of life and increased viral load among a sample of 178 HIV-positive men
(Pantalone, Hessler, & Simoni, 2010). Other recent research which has focused on the
occurrence of intimate partner violence experienced by women has suggested that intimate
partner violence and interpersonal violence may lead to higher viral load and increased riskybehavior, including medication nonadherence (Rose, House, Stepleman, 2010; Trimble, Nava, &
McFarlane, 2013). Important to note is that viral load could be an indicator of nonadherence to
medication or even virologic failure.
In a study conducted in Southern California, data was collected from 914 Latina
participants relating to history of abuse (Newcomb, Locke, & Goodyear, 2003). Researchers
explored variables such as family abuse, sexual abuse, and family neglect and their relationship
with outcomes such as HIV-attitudes and HIV-related behaviors. Using structural equation
modeling, the researchers concluded that childhood experiences of abuse do play a role in
predicting HIV-related risk among other negative effects such as psychosocial functioning. A
large study based on the Behavioral Risk Surveillance System Survey (Kessler et al., 2010)
involved assessing for experiences of sexual, psychological, and physical abuse in 48,526 adults
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from five U.S. states (Campbell, Walker, Leonard, & Egede, 2016). Multiple logistic regression
models were used to find relationships between experiences of abuse during childhood and
health outcomes. Researchers found that sexual abuse and verbal abuse predicted risky HIV
behavior and depression. This information is important and relevant especially since childhood
abuse and violence are especially prevalent among ethnic minorities, including Latino/as. In
studies conducted among Latino MSM, it has been found consistently that rates of childhood
abuse seem to be higher when compared to non-Latino MSM (Balsam, Lehavot, Beadnell, &
Circo, 2010; Feldman & Meyer, 2007).
Impulsivity
Psychiatric disorders and symptoms are more prevalent in people living with HIV/AIDS
and individuals with a diagnosable psychiatric disorder are more likely to be nonadherent to their
medication regimen (Bing et al., 2001; Gonzalez, Batchelder, Psaros, & Safren, 2011),
Additionally, impulsivity and depression have been reported in association with poor adherence
to medication among HIV-positive individuals. In a study conducted with 103 participants, 56%
of whom were diagnosed with mood disorders, researchers found that the participants who
scored high on measures assessing sensation-seeking behaviors and impulsivity were less likely
to adhere to their medication (Liraud & Verdoux, 2001). This effect was found after controlling
for history of substance abuse. In a study conducted in Mexico City among HIV-positive
patients, levels of impulsivity and depression were measured among 1,350 patients, 89% male,
using the State Impulsivity Scale (Iribarren et al., 2011) and the BDI (Beck, Steer, & Brown,
1996). Levels of impulsivity were highest among patients who were depressed, suggesting
greater risk for poor adherence and risky sexual behaviors among depressed patients (VegaRamirez, et al., 2015).
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The Role of Cultural Competence in HIV/AIDS Treatment
Culture is a vital element in the helping process since it is rooted in how circumstances
are defined and exhibited. Culture influences how a person seeks help, how services are
provided, and the treatment options (Pinderhughes, 1989). Cultural competence is the foundation
of effective and ethical practice in healthcare and encompasses a set of behaviors, skills,
knowledge, attitudes, and policies which together enable the system to function effectually in
cross-cultural scenarios (Pardasani, Moreno, & Forge, 2010). Cultural competence in the context
of HIV work is a process of continuous learning and development demanding the
unpretentiousness to accept that it will be unfeasible to comprehend all aspects of the cultures
with which one will have contact. However, as practitioners continue to serve others of diverse
backgrounds with an openness to learning, practitioners invite understanding and appreciation
for cultures different than their own and are better able to have empathy for different
worldviews. Additionally, practitioners will be more apt to modify and adjust interventions for
culturally diverse individuals (Cross, Bazron, Dennis, & Isaacs, 1989).
Researchers have identified critical skills and have advocated for the necessity of
culturally relevant treatment models, prevention strategies, and harm reduction models in their
conceptualization of cultural competence. For example, an explanatory system was developed to
understand the importance of a person’s worldview and assessment tools were developed to
assist in the evaluation of cultural competence levels among practitioners within the HIV service
field (Meleis, 1999; Vinh-Thomas, Bunch, & Card 2003). In the aforementioned assessment,
personal biases and values, understanding of the population’s worldviews, respect for diversity,
nonjudgmental and affirming attitudes, community involvement, and cross-cultural relationship
skills were evaluated. It is imperative that HIV health care providers avoid stereotyping members
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of any cultural or ethnic group and that they understand individual life perspectives (TaylorBrown, Garcia, & Kingson, 2001). Additionally, advocating for safe, integrated, and supportive
communities where human rights are protected are promoted should also be stressed (Rowe,
2007).
Pardasani, Moreno, and Forge (2010) developed a conceptual model for cultural
competence in HIV work which includes several interlocking systems and factors for
consideration within each of the four domains: Individual, Family, Organization, and Society and
Community. Within each of these domains, they stress the importance of values, beliefs, norms,
religion, socioeconomic status, and language as common threads which have an impact on each
of the four interlocking systems. The researchers additionally highlight the consideration of the
impact of stigma, support, and organization and public policy as influential factors in an
individual’s experience of HIV/AIDS.
Cultural Considerations in Mexican Population: Variables Influencing Mental Health
In Mexico, national prevalence of depression was 3.3% in 2017, affecting more women
than men (“La depresion afecta al 3.3%”, 2017). Regarding mental health and HIV/AIDS work
with Latinx-identified communities in the United States and with individuals in Mexico, certain
factors must be kept in consideration. Gender inequality in heterosexual relationships, traditional
patriarchal hierarchies, religion, idiosyncrasies of language, and sexual norms on high-risk
sexual behaviors are all factors that must be highlighted in work with this population (CDC,
2017; Galanti, 2003; McQuiston & Flaskerud, 2003; VanOss-Marin, 2003). For example, in
Latin American cultures, the cultural beliefs of machismo and mariansimo have the capacity to
negatively impact both heterosexual and homosexual relationships (Moreno, 2007). The
following sections present culture-specific factors which may be associated with increased
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psychiatric morbidity, psychological distress, and specifically, depression in persons living with
HIV/AIDS in Mexico.
Family-related issues and social stigma. A diagnosis of HIV can immensely impact
one’s social and family life. Fear of disclosing one’s status is common and often results from
perceived social stigma. Perceived social stigma due to HIV diagnosis has been associated with
increased chronic stress from social isolation and a decreased quality of life (Block, 2009; Foster
& Gaskins, 2009). A strongly held value in Mexico, familiarismo, conveys a sense of loyalty to
the family. While family is certainly a source of great support, it can also be a source of
significant challenges when considering issues relating to HIV, sexual orientation, and substance
use. Individuals who fear disclosing their seropositive status to family members may isolate from
their support system in turn increasing levels of psychological distress. For individuals who
experience challenges with their family unit, it will be important for clinicians to understand the
impact on the individual as well as to help them find alternate sources of support (Lescano,
Brown, Raffaelli, & Lima, 2009). Presence of social supports and sense of belonging have been
linked to better psychological adjustment and reduced stress in individuals with HIV.
Conversely, social isolation subsequent to negative HIV/AIDS-related stigma is an adverse
outcome of HIV often experienced by those diagnosed. Living alone or with someone other than
a partner has been associated with the presence of a current psychiatric disorder among people
receiving treatment for HIV/AIDS (Wolitski, Pals, Kidder, Courtenay-Quirk, & Holtgrave,
2009).
Two contributing factors to increasing the risk in promoting transmission of HIV
infection in Latin American communities are machismo and marianismo. Pressures to fit into
heteronormative stereotypes and roles may present a barrier to a Latino man acknowledging and
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accepting high-risk behaviors such as having sex with other men. The desire to conceal these
behaviors may influence the desire to portray oneself as heterosexual thereby providing
inaccurate portrayals of one’s sexual behavior. This causes an additional barrier as it further
complicates access to education, prevention, and treatment efforts. (Centers for Disease Control,
2017).
While machismo may not be the norm in each household, it is certainly present at
community and societal levels. In households where values and practices are influenced by
machismo, women may feel powerless and unable to assert themselves even in situations as
negotiating safe-sex. Condom use may be unacceptable as it may be contrary to religious beliefs
or may imply a lack of trust. These situations can be potentially dangerous as they may lead to
violence (Fernandez, Ruiz, & Bing, 1998). In this same vein, marianismo conveys the idea that
women should be submissive to their male partners, as such, many traditional households are
centered around the husband (Peragallo, 1996).
Gender and sexual orientation. Gender and sexual orientation play important roles in
examining mental health in HIV-positive individuals. Gay men, for example, while more likely
to contract HIV are already more likely to be depressed. In a study conducted in Mexico City by
Caballero-Suarez, Rodriguez-Estrada, Candela-Iglesias, and Reyes-Teran (2017), data was
collected from a cross-sectional survey conducted between 2012-2013 at a specialized clinic in
Mexico City which focused on condom use and serostatus disclosure. Sociodemographic
information, time since HIV diagnosis, CD4 counts, and viral load of the previous six months
were acquired. Additionally, a version of the Beck Depression Inventory and Beck Anxiety
Inventory, both adapted to the Mexican population and to Mexican persons living with HIV,
were administered. In this sample of 291 persons, 13% identified as women, all heterosexual. Of
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the men in the study, 22% identified as heterosexual. There were no significant differences
between men and women in terms of viral load, CD4 counts or time since diagnosis; however,
more women than men self-reported current psychiatric treatment. The researchers found that
women who have HIV have higher rates of depression and anxiety than do men with HIV.
Moreover, it was found that women with HIV generally have a lower quality of life than men
who are living with HIV. Research has also shown that a diagnosis of major depression was four
times greater in women who were diagnosed with HIV than women who were not. Suicidal
ideation and attempts of suicide are also recorded to be greater among HIV-positive women than
HIV-positive men.
While Mexico City and other urban centers of Mexico tend to be more tolerant of
homosexuality and the LGBT community, overall, homosexuality is rejected. This is tied into
other factors such as machismo and religion. This dynamic creates a complex interaction of
factors which can contribute to increased depression in individuals diagnosed with HIV.
Religion. In Mexico, religion is a core element of life. It is a country rooted in
fundamental teachings of Catholicism, a major presence for the past five centuries. The
transmission of HIV often occurs within the context of behaviors frowned upon by Catholic
teachings. In a society where religion influences not only outlook on life but also labeling of
behaviors, many individuals faced with the tribulations of an HIV infection or circumstances can
feel ostracized by faith groups, family members, or society (Instone & Mueller, 2011).
Importance of Current Study
Medication adherence is vital for HIV/AIDS patients. However, research has shown that
adherence continues to be an issue among individuals living with various chronic illnesses. In the
United States, it is estimated that more than 25% of patients with chronic conditions are
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nonadherent to their prescribed medication regimens with an annual cost of nonadherence
estimated to be near $290 billion US dollars (Taitel, Jiang, Ewing, & Duncan, 2012). While HIV
medication has improved and become more accessible in many parts of the world, rigorous
adherence to the medication remains an essential part of treatment for improved health outcomes,
and avoidance of virologic failure and drug resistance. Psychological and social factors have
been well-documented in research as contributing factors to negative health outcomes and poor
adherence to HIV medication in the United States and Mexico. According to the U.S.
Department of Health and Human Services (2016), several factors contributing to nonadherence
are side effects of medication, busy schedule and travel, unstable living conditions, illness or
depression, substance use, fear of disclosing HIV status, or lack of health insurance or finances
to cover the cost of medication. This knowledge supports the need for early intervention
strategies and early screening for risk factors which could contribute to medication
nonadherence. Due to the variability found in the literature regarding adherence, there are
existing implications for repeated studies and testing within new groups of individuals across
cultures and the need for integrative care and collaboration among medical professionals and
mental health professionals. By streamlining care to include better communication and
collaboration among mental health professionals and physicians, there is greater potential for
improved patient outcomes, holistic care, and improved intervention strategies (Winfield,
Sparkman-Key, & Vajda, 2017). A retrospective cohort study conducted in the Midwest of the
United States, evaluated a program which was designed to improve adherence to medication
among new patients receiving statin therapy. The program involved face-to-face counseling
sessions with pharmacists who utilized motivational interviewing techniques to assist patients
with their medication adherence. Adherence was measured using a medication possession ratio
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and was based on the benchmark of 80% adherence which is commonly used in medication
adherence research. Researchers found that patients who participated in the counseling program
exhibited greater adherence to their medication regimen than patients who were part of the
comparison group and received usual care. This study not only highlighted the effectiveness of
brief counseling interventions to improve medication adherence but showed the potential for the
involvement of counseling professionals who could participate in the training and coaching of
medical staff in motivational interviewing, empathic responding, and screening for various
psychological risk factors for medication nonadherence.
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CHAPTER 3
METHODOLOGY
This chapter describes the methodological design of the study on HIV, medication
adherence, mental health, and psychosocial factors. First, this section explains the purpose of the
study and research questions which guide the study. Next, the quantitative research design of the
study and sequential logistic regression model are discussed. Detailed information regarding
participants, data collection, and relevant instrumentation are provided. Finally, information
regarding validity of the methodological design is explained.
Purpose and Research Questions
The purpose of this study was to examine the relationships among psychosocial factors,
immune functioning, and medication adherence in HIV-positive individuals. The researcher
intended to investigate these relationships to contribute to improved interventions in integrative
care settings. Based on prior literature the following research questions guided this study:
1. What is the relationship between CD4 counts and violence, disclosure, and social support
in HIV-positive individuals?
a.

H1: Exposure to violence will have a negative relationship with CD4 counts.

b.

H2: Social support will have a positive relationship with CD4 counts.

c.

H3: Individuals who received an accepting response from family members will
have significantly elevated CD4 counts in comparison to those who did not
disclose their status, or received a rejecting or indifferent response.

2. To what extent do disclosure, social support, impulsivity, and exposure to violence
predict medication adherence in HIV-positive individuals after controlling for depression
and major stressors experienced within the past year?
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a. H4: Rejection and indifference from family members, impulsivity, exposure to
violence, and decreased social support will increase the probability of
nonadherence to medication.
Research Design
The dissertation utilized a nonexperimental, cross-sectional research design. This data is
cross-sectional since the data was recorded from a specific group at a single point in time
(Thompson & Panacek, 2007). Cross-sectional research provides a naturalistic view of the
investigated phenomena due to lack of researcher influence which often exists in experimental
research in which variables are intentionally manipulated (Field, 2017). The majority of the data
in this study was self-report collected via intake questionnaire and a battery of self-report
assessments. Clinical mental health and medical professionals provided additional information
on the intake forms in regard to mental health diagnoses, mental health issues identified as
barriers to treatment, and CD4 counts and viral load as determined by laboratory blood tests.
This study investigated psychosocial phenomena that were measurable and objective,
therefore supporting the use of quantitative linear methods to test the research questions
(Bernard, 2013). Previous research on HIV-positive individuals focusing on adherence have used
a variety of research designs and analyses to study factors influencing medication adherence and
nonadherence among people living with HIV/AIDS. Studies reported in the literature utilized
bivariate and multivariate logistic regression models, however, lacked sequential analyses to
control for the influence of pre-existing psychological variables (e.g. Chandwani et al., 2012;
Rotzinger et al., 2016; Weaver, Pane, Wandra, & Windiyaningsih, & Samaan, 2014). Most
recently, in a study conducted in a northern state of Mexico, researchers used structural equation
modeling to examine psychological influences on antiretroviral medication adherence in a
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population of Mexican people living with HIV/AIDS. This study included variables such as
decision-making, tolerance of ambiguity, tolerance of frustration, motivates to behave,
depression, and social support (Sagarduy et al, 2017). In this model, social support and
depression were found to be nonsignificant in relationship with medication adherence, unlike
other analyses mentioned in the literature where depression and social support were found to be
significant (Grenard et al., 2011; Gonzalez et al., 2009). In the field of HIV/AIDS research,
contradictory literature is the norm, requiring specific models to be tested within new
populations in differing geographic regions, cultures, and ethnic groups. The current data set had
never been analyzed and contributes to the body of literature on people living with HIV/AIDS.
To better understand the relevance of psychosocial factors in the role of medication adherence in
the population of HIV-positive individuals in Mexico City, a regression analysis was most
helpful since regression analyses assist in studying the relationships between several predictor
variables and an explicit outcome (Heppner, Wampold, & Kivlighan, 2008). For this study, a
sequential logistic regression analysis was utilized in which the researcher specified the order of
entry of the predictor variables based on a theoretical rationale (Petrocelli, 2003; Tabachnick &
Fidell, 2014). Since contradictory findings present themselves in the literature, a sequential
logistic regression controlled for pre-existing psychosocial variables (e.g. depression and major
stressors experienced within the past year) based on the theoretical framework presented in
Chapter Two to provide knowledge of the extent to which disclosure, exposure to violence,
social support, and impulsivity impact medication adherence in this population. The researcher
entered the pre-existing psychosocial variables first to control for the effects of these variables to
understand the effects of disclosure, social support, impulsivity and violence beyond that
accounted for by depression and other major stressors. This allowed the researcher to perform a
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more rigorous analysis of the relationship between the variables of interest and medication
adherence.
Included in the model for the current study were 6 predictor variables: disclosure
(categorical), social support (continuous), exposure to violence (continuous), stressors
(continuous), impulsivity (continuous), and depression (continuous). The outcome variable was a
binary categorical variable, medication adherence to antiretroviral medication for HIV treatment.
All participants in the sample had been diagnosed with depression by a clinician but had varying
BDI scores. Additionally, patients recorded the number of major stressors experienced within the
past year. As such, depression scores and stressors were included within the first block of the
sequential regression model to control for the effects of these variables. Disclosure, social
support, exposure to violence, and impulsivity were included in the second block of the
sequential regression model. This model was utilized to analyze two subsets of the data which
were subsequently created after the initial data screening in order to account for uneven groups
in the dependent variable. Additionally, bivariate correlations were conducted to determine
relationships between CD4 counts, social support, and exposure to violence and a one-way
ANOVA was conducted to determine if significant mean differences existed between disclosure
groups.
Data Collection
Data was collected by mental health clinicians from 2010-2016 at a large specialized
clinic in Mexico City. The clinic serves individuals who are living with HIV and AIDS providing
them with ART, psychological services, and a variety of other medical services. The clinic has
no formal Institutional Review Board process in place in order to collect the data. In this clinic,
mental health clinicians work and function as part of a separate mental health department with

43
their own set of protocol and work flow procedures. Most typically, patients arrive to the clinic
to receive free HIV testing from the medical team. Once a patient has been diagnosed with HIV,
the patient is sent for laboratory blood tests to obtain viral load and CD4 counts. The patient is
also referred to the mental health program for a psychological evaluation, a brief intervention,
and a treatment plan. The psychological evaluation consists of a comprehensive intake form and
a battery of 6 assessments. The intake form and 2 of the 6 assessments are part of the current
study and will be explained in more detail in the section regarding instrumentation. Other
patients referred to the mental health program for evaluation are transgender-identified
individuals who are both HIV-positive and HIV-negative, and HIV-positive individuals who
have been diagnosed elsewhere prior to presenting to the specialized clinic. In the current data
set, the researcher used a subset of individuals all diagnosed with HIV.
Participants
Sampling Criteria
The researcher used a sample from an archival data set which was based on specific
criteria. The purpose of this study was not generalizability, but investigation of a specific
population in a particular geographic region, of which this sample is representative. Inclusion
criteria for this study was a diagnosis of HIV or AIDS, current prescribed antiretroviral
medication regimen, sexually transmitted HIV, and a clinician diagnosis of depression. This
resulted in a total of 601 participants to be included from the original data set which included
data of 4,842 patients. In the data set containing 601 participants, the two groups of the
dependent variable were uneven. As a result, two random samples were taken from the larger
group (“adherent”) and assigned to two smaller subsets including the full nonadherent group to
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create two subsets of 146. This number was determined through a power analysis discussed in
the next section.
Power Analysis
Power represents the ability to correctly reject a null hypothesis. It is a function of the
magnitude of the effect, the probability level chosen for statistical significance, and the sample
size used in the study (Keith, 2015). The researcher used G*Power 3.1 to determine the
minimum sample size necessary to yield significant results in a sequential logistic regression
analysis. For an analysis with a medium effect size (f2) of .15, error probability (α) of .05, power
(β) of .95, and six predictor variables, the power analysis indicated an optimal sample size of
146. According to Cohen (1988, 1992), researchers should achieve a minimum power of .80. The
statistical power of the current study indicates that there was a 95% chance of detecting an effect
if it existed.
Participant Demographics
All participants were patients at a specialized clinic in the center of Mexico City residing
in one of Mexico City’s 16 boroughs or in close proximity to the city limits. Of the 146
participants included in Data Set 1 of this study, 122 identified as male, 20 identified as female,
and 2 identified as transgender female. Age ranged from 17-67. For marital status, 110
participants were single, 33 were married or partnered, and 3 were widowed. Regarding
occupation, 44 of the participants were unemployed at the time of their intake. In terms of
religion, 72 of participants identified as Catholic. Regarding sexual orientation, 101 of
participants identified as homosexual, 12 as bisexual, and 30 as heterosexual. Lastly, 98 of
participants had a detectable viral load at the time of their intake and 44 had an undetectable viral
load.
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Of the 146 participants included in Data Set 2 of this study, 130 identified as male, 15
identified as female, and 1 identified as transgender female. Age ranged from 17-64. For marital
status, 115 participants were single, 29 were married or partnered, and 2 were widowed.
Regarding occupation, 38 of the participants were unemployed at the time of their intake. In
terms of religion, 72 of participants identified as Catholic. Regarding sexual orientation, 104 of
participants identified as homosexual, 16 as bisexual, and 26 as heterosexual. Lastly, 93 of
participants had a detectable viral load at the time of their intake and 50 had an undetectable viral
load.
Instrumentation
Participants completed two assessments as part of their initial intake at the clinic which
measured level of depression, and impulsivity. An intake form was also completed which
included self-report demographic information, medical data collected from healthcare
professionals at the clinic, and documentation of mental health disorders as diagnosed by mental
health clinicians at the clinic.
Escala de Impulsividad Estado/State Impulsivity Scale (EIE/SIS)
The State Impulsivity Scale is 12-item Likert-scale assessment created and validated in
Spain (Iribarren et al., 2011). The assessment, which is intended to measure an individual’s level
of impulsivity, views impulsivity not as a character trait, as have other assessments measuring
this construct, but as a state or temporary condition. The measure was based on three theoretical
notions including reward, automatism, and attention. Reward referring to impulses toward
achieving an immediate reward, automatism referring to repetitive behaviors without
reinforcement, and attention referring to premature response behaviors in situations where more
information was needed to act appropriately. The items in the EIE/SIS use a Likert-type response
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format ranging from 0-3 where 0 is “Almost Never”, 1 is “Sometimes”, 2 is “Often”, and 3 is
“Almost Always/Always”. Language in the EIE/SIS was carefully constructed in order to avoid
language framing impulsivity as a personality trait. Questions on the EIE/SIS include: “I seek
activities where I obtain rapid pleasure, even if they are harmful”, “I generally fall into
temptations that make it hard for me to fulfill a commitment”, “If I do something and do not
obtain the results I expect, it is hard for me to do something else”.
In order to test, validate, and standardize the instrument, the Iribarren et al. (2011)
conducted three phases in the study. During the first phase, the questionnaire was administered to
a sample of 110 participants from a community mental health center in Madrid. Problematic
items were removed which resulted in a 20-item questionnaire. During the second phase,
researchers established 3 groups: Impulsive Patients (IP), Non-Impulsive patients (NIP), and a
Control Group (CG). Participants in the IP group were diagnosed by a psychiatrist as having at
least one impulse control disorder as defined in the DSM-IV-TR. Participants in the NIP group
were diagnosed with other psychiatric disorders. In the second phase, participants were
administered the EIE/SIS along with the Barratt Impulsivity Scale (BIS-11), the Sensitivity to
Punishment and Sensitivity to Reward (SPSR) Questionnaire, and the Sensation Seeking Scale
(SSS). During the final validation stage, researchers obtained a sample of 293 participants which
were categorized into the same three groups, IP, NIP, and CG. The principal diagnoses among
the IP group were intermittent explosive disorder, pathological gambling, kleptomania, and
borderline personality disorder. Among the NIP group, the principal diagnoses were major
depression disorder, anxiety disorders, anorexia nervosa, schizophrenia, alcohol dependence, and
somatoform disorder. The range of ages in the sample was 18-68 with the following means: IP

47
(M = 40.27), NIP (M = 38.23), CG (M = 31.97). Researchers compared the IP and NIP group and
found no significant differences between age, gender, work situation, and educational level.
To measure reliability, researchers used a test-retest correlation which resulted in a
Cronbach’s alpha of α = .884 (F = 7.638, n = 293, p = 0.000) (Iribarren et al., 2011). Using the
split-half method, researchers found strong internal consistency (r = .644, p = 0.000). Construct
validity was analyzed with principal component factor analysis supported by Bartlett’s test of
sphericity and Kaiser-Meyer-Olkin test. The Kaiser-Meyer-Olkin measure of sampling adequacy
was .982, above the commonly recommended value of .6 (Hutcheson & Sofroniou, 1999), and
Bartlett’s test of sphericity was significant (χ2 (1913) = 5129, p < .05). Factorization was stopped
after the extraction of three anticipated factors corresponding to the theoretical foundation of the
instrument. The three factors, Reward, Automatism, and Attention explained 51.4%, (α = .840),
51.3% (α = .809), and 41.5% (α = .756) of the total variance, respectively. Convergent validity
was assessed by correlating total scores of the EIE/SIS to the BIS, SPSRQ, and SSS. A strong
correlation was found between the total scores of the EIE/SIS and total scores of the BIS (r =
.612, p = .000). A significant correlation was found between the EIE/SIS and the SPSRQ
subscale, Sensitivity to Reward (r = .452, p = .000) but not with the subscale Sensitivity to
Punishment (r = .117, p = .072). A moderate relationship was found between total scores of the
EIE/SIS and the SSS (r = .382, p = .008).
This instrument was subsequently adapted from the original version to fit the treatment
needs of the specialized clinic in Mexico City. Researchers at the clinic determined that their
adapted version was reliable and valid for HIV-positive patients in Mexico City achieving
stronger coefficients than those found during the validation process in Spain. Researchers
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determined the instrument’s internal consistency to have a reliability (α) of .92 with mean interitem correlations, r = .71, KMO = .93.
Beck Depression Inventory
The Beck Depression Inventory is a 21-item self-report questionnaire which is intended
to measure the occurrence and severity of depressive symptoms (Beck, Steer, & Brown, 1996).
This questionnaire has often been seen as the gold standard in the screening of depression. In a
meta-analysis on the English version of the BDI-II, Erford, Johnson, and Bardoshi (2016) review
psychometric properties of the BDI-II including the test-retest reliability, convergent validity,
structural validity, and diagnostic validity based on this review of the literature and previous
studies.
Many studies have been conducted on the BDI-II which have examined the psychometric
properties of this instrument. eck, Steer, and Brown (1996) administered the instrument to 500
outpatients and 120 college students. It was determined that the BDI-II had high internal
consistency across both groups, college students (α = .93) and outpatients (α = .92). When using
a sample of 26 participants from the outpatient group, the instrument demonstrated excellent testretest reliability (r = .93). In the meta-analysis of the BDI-II, Erford, Johnson, and Bardoshi
(2016) combined a total of 99 studies to analyze internal consistency of the instrument. With a
combined sample size of 31,413, internal consistency averaged α = .907 in clinical samples. To
examine test-retest reliability, 12 studies were combined for a total sample of 1,562 which
resulted in a test-retest reliability of rtt = .75. In clinical samples (n = 572), researchers found an
average rtt of .68.
Researchers compared the BDI-II to 43 other depression inventories (Erford, Johnson, &
Bardoshi, 2016). Of the 43 depression inventories included in their analyses, three instruments
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provided more than three convergent comparisons with the BDI-II: Center for Epidemiological
Studies-Depression, r = .72 (Radloff, 1977); Hamilton Depression Inventory, r = .74 (Hamilton,
1960); and the Zung Depression Rating Scale, r = .53 (Zung, Richards, Gables, & Short, 1965).
Important to note is that the BDI-II is a criterion-referenced instrument used as a screening tool
to assist in the diagnosis of depression. Since it is a criterion-referenced instrument, the BDI-II
may be culturally biased. Its diagnostic validity may be variable dependent on the population
with which it is utilized (Drew, 1973; Erford, Johnson, & Bardoshi, 2016). While the BDI-II has
been adapted across settings to be interpreted at differing cut-off scores for depression, Beck,
Steer, and Brown (1996) suggested the following interpretations: 0-13 as minimal, 14-19 as mild,
20-28 as moderate, and 29-64 as severe.
The BDI-II has been translated to a multitude of languages worldwide, including Spanish.
In Mexico, an adaptation of the BDI-II was piloted and validated using a sample of students from
across Mexico and a sample of adults from the community in Mexico City (González, Reséndiz,
& Reyes-Lagunes, 2015). Both the sample of students (α = .92) and adults from the community
(α = .87) had high levels of internal consistency. A factorial analysis resulted in a three-factor
model which has been supported in English-speaking populations (Osman, Barrios, Gutierrez,
Williams, & Bailey, 1997). This model may even be a more appropriate fit for use in the
Mexican population since specific items pertaining to affective characteristics which did not
have strong loadings on cognitive or somatic factors were separated (González et al., 2015;
Ward, 2006).
Evaluación de Primera Vez de Salud Mental – V9/Mental Health Intake Evaluation Form
The specialized clinic in Mexico City developed a comprehensive intake form for
utilization in their mental health program. The intake form was part of the initial assessment at
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the clinic upon referral to the mental health program. The intake questionnaire was
predominantly self-report with demographic items as well as questions addressing psychosocial
concerns pertinent to HIV/AIDS illness and treatment. Demographic items included age, gender,
marital status, living situation, work situation, religion, chronic illness, and mode of HIV
transmission. Psychosocial concerns addressed include violence and assault, mental health
diagnosis, stressors experienced within the last year, family history of mental health issues,
previous psychological treatment, suicidality, medication regimen and adherence, disclosure to
family members, and social support. Included in the initial evaluation are items which ask for
viral load and CD4 counts. These measures were obtained by laboratory blood work during the
initial visit. Additionally, the mental health clinician completing the evaluation provided a
mental health diagnosis or indicated that the patient did not have a diagnosable psychiatric
disorder.
Procedure
In this section, the data cleaning process is discussed. The proposed analysis and
associated assumption checking are also described in this section. Finally, threats to internal and
external validity and other limitations to methodology are reviewed.
Data Cleaning
The current data set obtained from the clinic contained information from 4,842 patients.
To fit the purpose and goals of this study, the researcher focused on a subset of the data based on
specific criteria. The criteria included a diagnosis of HIV or AIDS, current prescribed
antiretroviral medication regimen, sexually transmitted HIV, and a clinician diagnosis of a
mental health disorder. First, a new data set was created, including all participants who have
been diagnosed with one of the following mental illnesses by a clinician at the clinic: major
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depression, generalized anxiety disorder, schizophrenia, personality disorder, post traumatic
stress disorder, adjustment disorder, and bipolar disorder. Cases were removed for patients who
had not been transmitted HIV sexually and who were not currently prescribed an antiretroviral
medication regimen at the time of intake. A missing values analysis was conducted for all
variables included in the analyses to determine if more than 5% of the values are missing. Cases
in which more than 25% of responses on EIE/SIS or BDI are missing were removed and missing
data was imputed using expectation maximization. The reduction of the data set resulted in a
final total of 601 participants.
Prior to running the analysis, assumptions for sequential logistic regression were
checked. There must be one dichotomous dependent variable, in this case medication adherence
which is categorized into “Yes” and “No” (Tabachnick & Fidell, 2008). There must be one or
more independent variables, either continuous or nominal scale (Tabachnick & Fidell, 2008).
Observations and categories of the dichotomous dependent variable must be independent and
nominal independent variables should be mutually exclusive and exhaustive
(Statistics.laerd.com, 2013). Independent variables were checked to confirm a minimum of 15
cases per independent variable to avoid an overfit model (Stoltzfus, 2011). The researcher also
checked the assumption of linearity which requires a linear relationship between the continuous
independent variables and the logit transformation of the dependent variable. This assumption
was checked using the Box-Tidwell approach (Box & Tidwell, 1962). The researcher inspected
correlation coefficients to check for absence of multicollinearity, to report whether independent
variables were highly correlated with one another. Multicollinearity arises when numerous
independent variables correlate with one another at an exceptionally high level or when an
independent variable is a near linear combination of other independent variables (Keith, 2015).
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This is problematic and could lead to misleading results and the inability to separate the effects
of the predictor variables. Lastly, the data was screened for significant outliers which could
influence the impact the data has on the regression line.
Analysis
Data analyses were conducted with SPSS software version 25. For the first research
question, a correlational analysis was conducted in order to examine the relationships between
the continuous variables social support, violence, and CD4 counts. Next, an ANOVA was
conducted to estimate the mean differences in CD4 counts among disclosure groups. For
research question two, a logistic regression model was utilized to estimate the contribution of
each predictor variable while simultaneously taking other predictor variables into account and
was tested across two groups, each composed of the smaller nonadherent group and a random
sample of the adherent group due to the unbalanced levels in the outcome variable. This strategy
was utilized in order to assess the generalizability of the model (Chan, 2004; Katz, 1999). The
analyses were conducted in two steps into which BDI scores and stressors were entered first
followed by psychosocial variables of interest to identify the influence of depression and stress
before taking other possible risk factors for medication nonadherence into account.
Logistic regression allows one to predict a discrete outcome from a set of variables that
may be continuous, discrete, or dichotomous (Tabachnick & Fidell, 2008). It is a popular
analysis used in health sciences as it allows researchers to test for a discrete outcome such as
adherence/nonadherence based on a number of predictor variables. Additionally, logistic
regression is a flexible analysis in which assumptions of distribution normality do not exist
(Tabachnick & Fidell, 2008). In this study, the variables of interest included disclosure of HIV
status to family members (predictor variable, nominal), social support (predictor variable,
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continuous), exposure to violence (predictor variable, continuous), impulsivity (predictor
variable, continuous), BDI scores (predictor variable, continuous), number of stressors
experienced within the past year (predictor variable, continuous), and medication adherence
(outcome variable, nominal). Sequential logistic regression was a useful analysis to show how
much of the variance in the dependent variable, medication adherence, is explained by the
predictor variables (disclosure, impulsivity, exposure to violence, social support) after
controlling for number of stressors experienced within the past year and BDI scores (Field,
2017). The order variables entered into the sequential regression model should be based on
previous literature (Heppner, Wampold, & Kivlighan, 2008; Tabachnick & Fidell, 2008). Since
much of the literature on the relationship between medication adherence and psychosocial factors
in HIV/AIDS patients is inconsistent, contradictory, and variable dependent on the specific
population, the researcher aimed to create a regression model to examine the effects of specific
psychosocial factors among HIV/AIDS patients at the clinic in Mexico City based on the
Transactional Model of Stress and Coping (Lazarus & Folman, 1984).
Due to the nature of medication being a self-report measure, it is likely that nonadherence
was underreported resulting in a skewed representation of the groups in the dependent variable.
Due to the imbalanced nature of the groups in the dependent variable, medication adherence, two
random samples were taken from the adherent group in order to achieve balanced group sizes in
the dependent variable. By running two separate logistic regressions, a wider range of the
adherent group was examined. Additionally, the rationale for randomly selecting cases from the
adherent group was to ensure that statistical power, according to a priori analyses, was reached.
Threats to Internal and External Validity
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Important to understanding the validity of the study, it is vital to review the threats to
internal and external validity existent due to the study design and methodology. Having a better
understanding of these threats guides the researcher to draw valid conclusions about research
questions by generating alternative explanations for the study’s results (Heppner, Wampold, &
Kivlighan, 2008). These considerations of validity are important for those who design, conduct,
and consume research. The researcher intended to consider these threats to internal and external
validity with the expectation that relatively valid conclusions resulted from the analyses.
Internal validity is the extent to which the study design supports the possibility that
variances in the predictor variables caused a difference in the dependent variable. Since the
current study was non-experimental correlational research, the study had low internal validity
due to lack of researcher manipulation and lack of attributable causation (Heppner, Wampold, &
Kivligahn, 2008). External validity refers to the generalizability of a study’s results to the
population and across populations (Cook & Campbell, 1979; Heppner, Wampold, & Kivligahn,
2008). This study had good external reliability as the results from this sample could apply
directly the population. However, generalizability may not be applicable across groups as
evidenced by the inconsistencies in HIV/AIDS literature in terms of the relationships between
psychosocial factors and social support. Lastly, since much of the data was derived from selfreport measures, the data was vulnerable to influence of response bias, especially since patients
may had felt pressured by stigma, the urgency of medication adherence, and other aspects
relating to the diagnosis of HIV/AIDS.
Summary
This chapter focused on the purpose of the study, the research design, and the data
collection process. Additionally, information regarding the sampling process and instrumentation
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used in the study was provided. The data analysis procedure and associated threats to external
and internal validity was discussed.
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CHAPTER FOUR
RESULTS
The purpose of this study was to investigate the relationship between disclosure of HIV
status to family members, social support, impulsivity, exposure to violence, and medication
adherence among a sample of HIV-positive individuals in Mexico City. This study aimed to add
to the existing body of literature focusing on issues in HIV and AIDS care as well as literature
focusing on interprofessional collaboration research. In the analysis, this study controlled for
factors known to contribute to medication adherence based on previous research, specifically
major life stressors and depression. In this chapter, the researcher reviewed the results of the
statistical analyses from the current study, including more detail regarding data cleaning and
preliminary assumption checking analyses.
Data Screening and Preparation
The data were screened for inclusion criteria, data entry errors, missing values, and the
assumptions for the logistical regression analyses resulting in 601 valid cases (or participants).
Within the valid cases, 533 of the participants indicated adherence to their medications and 68
indicated nonadherence creating unequal groups in the outcome variable. Unequal groups in the
outcome variable potentially can lead to skewed probabilities in the analysis which would in turn
compromise the predictions calculated by the logistic regression. To adjust for the unequal
groups, the nonadherent group, which was the smaller group consisting of 68 individuals was
copied into two separate data sets, called Data Set 1 and Data Set 2. To create two whole data
sets ready for analysis, two random samples of 78 participants were taken from the larger
adherent group containing 533 participants. Two samples were taken so that each group of 78
participants could be assigned to one of the newly created subsets of data. Now each data set
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included 146 participants. This was done in attempts to best represent the characteristics of the
full data set and also to ensure minimum sample size required according to an a priori G*Power
analysis.
Recoding
Violence, stressors, and disclosure responses were gathered via intake questionnaire
checklists. For example, participants were asked whether they had experience psychological,
emotional, physical, or economic abuse during the course of their lifetime. This variable was
recoded as an ordinal variable ranging from 0-4 where 0 indicated no exposure to violence, and 4
indicated exposure to each of the types of violence listed in the questionnaire. Stressors
experienced during the past year was included as a checklist of 7 different stressors on the intake
evaluation which was coded as an ordinal variable in the data set where 0 indicated no exposure
to major stressors and 7 indicated exposure to all stressors listed in the questionnaire. Two
variables in the data set corresponded to disclosure to family of HIV or AIDS status. These
variables were transformed to create a new variable which was coded as 0 for no disclosure to
family of HIV status, 1 for disclosure to family with reaction of support, 2 for disclosure to
family with reaction of rejection, and 3 for disclosure to family with reaction of indifference.
BDI and EIE scores were aggregated to form sum variables for each of the scales. BDI, EIE, and
social support variables did not need further coding or transformation as they are continuous
scale variables.
Data Analysis
Data analyses were conducted with SPSS software version 25. The two research
questions involved checking for assumptions and recoding variables if necessary. For the first
research question, a correlational analysis was conducted in order to examine the relationships
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between the continuous variables social support, violence, and CD4 counts. Next, an ANOVA
was conducted to estimate the mean differences in CD4 counts among disclosure groups. For
research question two, a logistic regression model was utilized to estimate the contribution of
each predictor variable while simultaneously taking other predictor variables into account and
was tested across two groups, each composed of the smaller nonadherent group and a random
sample of the adherent group due to the unbalanced levels in the outcome variable. This strategy
was utilized in order to assess the generalizability of the model (Chan, 2004; Katz, 1999). The
analyses were conducted in two steps into which BDI scores and stressors were entered first
followed by psychosocial variables of interest to identify the influence of depression and stress
before taking other possible risk factors for medication nonadherence into account
Research Question One: What is the relationship between CD4 counts and violence,
disclosure, and social support?
For the first research question, a correlational analysis was conducted in order to examine
the relationships between the continuous variables social support, violence, and CD4 counts.
Next, an ANOVA was conducted to estimate the mean differences in CD4 counts among
disclosure groups. Prior to running correlational analyses, data was screened to determine if a
linear relationship existed between the variables. Data was also screened for normality. The
researcher used SPSS to construct scatterplots and boxplots and to compute normality tests. The
violence, social support, and CD4 variables were determined not to be normally distributed
according to the Shapiro-Wilk’s test (p < .05). Due to non-normality of the data and
monotonicity as observed in the produced scatterplots, a Spearman correlation was conducted on
the three variables.
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Using SPSS, Spearman correlations were utilized to determine if a relationship existed
among violence, social support, and CD4 counts. Specifically, the researcher aimed to identify
relationships between violence and CD4 counts and social support and CD4 counts. In Data Set
1, the analysis showed a significant small positive correlation between violence and CD4 counts
(rs = .189, p < .05). In Data Set 2, neither violence nor social support were found to have
statistically significant relationships with CD4 counts.
Table 1. Correlation Coefficients (Spearman Correlation) of Violence, Social Support, and
CD4 Variables for Data Set 1.
Violence
Social Support
CD4
Violence

-

Social Support

-.212*

-

CD4

.189*

.055

-

Table 2. Correlation Coefficients (Spearman Correlation) of Violence, Social Support, and
CD4 Variables for Data Set 2.
Violence
Social Support
CD4
Violence
Social Support
CD4

-.272*

-

.112

.036

-

Prior to running the ANOVA to determine mean differences across disclosure groups,
assumptions were checked. Assumptions of a one-way ANOVA are a continuous dependent
variable, a categorical independent variable with two or more independent groups, independence
of observations, no significant outliers in the groups of the independent variable in terms of the
dependent variable, a normally distributed dependent variable for each group of the independent
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variable, and a dependent variable with a normal distribution. SPSS was utilized to construct
boxplots for each disclosure group and determined that there were no significant outliers among
each of the groups. A Shapiro-Wilk’s test determined that two groups (No Disclosure and
Acceptance from Family) were not normally distributed (p < .05) and the groups corresponding
to individuals who were rejected by family and whose families were indifferent to their
disclosure were approximately normally distributed (p > .05). A one-way ANOVA was
conducted to determine estimates of mean differences between disclosure groups on their CD4
counts. The analysis determined that there were no statistically significant mean differences in
CD4 counts between the groups.
Research Question Two: To what extent do disclosure, social support, impulsivity, and
exposure to violence predict medication adherence in HIV-positive individuals after
controlling for depression and major stressors experienced within the past year?
Screening of the data was performed separately to check for missing data, outliers,
linearity, and multicollinearity. The assumptions for logistic regression are the presence of one
dichotomous dependent variable, the presence of one or more independent variables of
continuous or nominal scale, independence of observations and categories of the dichotomous
dependent variable, mutually exclusive and exhaustive nominal independent variables, linearity
in the logit, the absence of multicollinearity, the absence of outliers in the solution, and
independence of errors.
The first assumption is the presence of one dichotomous dependent variable which is met
by the binary dependent variable medication adherence (0 = adherent; 1 = nonadherent). Next,
there are several independent variables in the study which are continuous or nominal.
Observations and categories of the dependent variable are independent of one another and the
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sole nominal independent variable, disclosure to family of HIV status, is mutually exclusive and
exhaustive.
Logistic regression assumes a linear relationship between continuous predictors and the
logit transformation of the dependent variable. To test for linear relationships between the
continuous predictor variables and the dependent variable, medication adherence, the BoxTidwell approach was utilized (1962). In the Box-Tidwell approach, interaction terms between
each predictor and its natural logarithm, are created and added to the logistic regression model to
screen for the violation of the assumption of linearity.
The first step of the Box-Tidwell approach was to compute the natural logit
transformation for each of the continuous independent variables using the compute variable
function in SPSS. After computing the natural logit transformation for social support, violence,
EIE aggregate score, BDI aggregate score, and stressors, a logistic regression needed to be run to
examine the presence of linearity. For this analysis, each predictor variable, including the
nominal variable disclosure, was added as a covariate in the analysis. Next, interaction terms
were created for each pair of continuous variable and their respective natural logit transformation
variable. This resulted in twelve terms in the model including six predictor variables, five
interaction terms, and the intercept. A Bonferroni correction was applied using all 12 terms in the
model resulting in statistical significance being accepted when p < .00417 (Tabachnick & Fidell,
2014). This number is calculated by dividing the accepted value of statistical significance (p =
.05) by the number of terms in the analysis. Based on this analysis, all continuous independent
variables were found to be linearly related to the logit of the dependent variable. See Table 3 and
Table 4 for detailed information regarding the analysis for checking this assumption.
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Table 3. Assumption Checking for Linearity of Data Set 1 Data.
Interaction Terms

B

S.E.

Wald

df

Sig.

Exp(B)

LnViolence*Violence

-2.427

3.078

.622

1

.430

.088

LnStressors*Stressors

3.004

2.266

1.757

1

.185

20.157

LnSocialSupport*SocialSupport

1.117

2.027

.304

1

.582

3.056

LnEIE*EIE

.304

.182

2.800

1

.094

1.355

LnBDI*BDI

.757

1.572

.232

1

.630

2.133

Table 4. Assumption Checking for Linearity of Data Set 2 Data.
Interaction Terms

B

S.E.

Wald

df

Sig.

Exp(B)

LnViolence*Violence

.383

.508

.570

1

.450

1.467

LnStressors*Stressors

-3.232

2.618

1.524

1

.217

.039

LnSocialSupport*SocialSupport

-2.478

2.171

1.302

1

.254

.084

LnEIE*EIE

.888

.626

2.014

1

.156

2.431

LnBDI*BDI

-.207

.506

.167

1

.682

.813

The researcher inspected correlation coefficients to check for absence of multicollinearity
to report whether independent variables were highly correlated with one another.
Multicollinearity arises when numerous independent variables correlate with one another at an
exceptionally high level or when an independent variable is a near linear combination of other
independent variables (Keith, 2015). This is problematic and could lead to misleading results and
the inability to separate the effects of the predictor variables. To check the assumption of
multicollinearity, a linear regression analysis was run to observe tolerance values, variance
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inflation factors (VIF), eigenvalues, condition indices, and variance proportions. According to
Field (2017), if eigenvalues in the collinearity diagnostics table produced by SPSS are much
larger than others, the uncentered cross-products matrix is ill-conditioned. This means that the
solutions of the regression parameters can be greatly affected by small changes in the predictor
variables. Additionally, it is suggested that tolerance values less than .1 and VIF values greater
than 10 indicate a potential problem with collinearity (Field, 2017; Menard, 1995; Myers, 1990).
In the results of the regression analysis of the continuous variables in Data Set 1,
tolerance and VIF coefficients indicate an absence of multicollinearity with tolerance values
ranging from .540-.966. Values of VIF ranged from 1.035-1.853. In the results of the regression
analysis of the continuous variables in Data Set 2, tolerance and VIF coefficients indicate an
absence of multicollinearity with tolerance values ranging from .476-.980. Values of VIF ranged
from 1.074-2.126. See Tables 5 and 6 for tolerance and VIF values of each variable.
Table 5. Collinearity Statistics for Data Set 1.
Predictor Variables in the
Model
Violence

Tolerance

VIF

.838

1.193

Disclosure

.966

1.035

Social Support

.914

1.094

Depression (BDI)

.551

1.814

Impulsivity (EIE)

.540

1.853

Stressors

.893

1.120

Table 6. Collinearity Statistics for Data Set 2.
Predictor Variables in the
Model

Tolerance

VIF
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Violence

.861

1.161

Disclosure

.980

1.021

Social Support

.911

1.097

Depression (BDI)

.475

2.105

Impulsivity (EIE)

.470

2.126

Stressors

.931

1.074

In regards to collinearity diagnostics, variance proportions must be analyzed for each
regression coefficient which can be broken down into eigenvalues. The variance proportions
indicate the proportion of the variance of each predictor’s regression coefficient that is attributed
to each eigenvalue. To determine if collinearity is present, it is important to ascertain whether
there are high proportions for more than one variable on the same small eigenvalue. If this were
the case, this would indicate that the variances of the regression coefficients are dependent. For
Data Set 1, this analysis showed that variance proportions across eigenvalues for the six
predictor variables did not reveal problematic results, indicating an absence of multicollinearity.
However, in Data Set 2, this analysis showed that for BDI scores 91% of the variance of the
regression coefficient is associated with eigenvalue number 7 and 72% of the variance of the
regression coefficient EIE scores is associated with the same eigenvalue. Since these predictors
have high proportions on the same small eigenvalue, it indicates that the variances of their
regression coefficients may be dependent. See Table 7 and Table 8 for more details of this
analysis.
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Table 7. Collinearity Diagnostics for Data Set 1.
Variance Proportions
Dimension

Eigenvalue

Condition

Constant

Violence

Disclosure

Index

Social

BDI

EIE

Stressors

Support

1

4.739

1.000

.01

.01

.01

.01

.01

.01

.01

2

.762

2.494

.00

.07

.00

.42

.03

.03

.01

3

.481

3.140

.00

.35

.04

.03

.11

.09

.12

4

.412

3.392

.01

.00

.55

.01

.00

.01

.40

5

.332

3.778

.00

.54

.16

.24

.00

.00

.41

6

.149

5.635

.35

.01

.09

.12

.28

.67

.00

7

.125

6.151

.63

.01

.15

.16

.58

.20

.04

BDI

EIE

Stressors

Table 8. Collinearity Diagnostics for Data Set 2.
Variance Proportions
Dimension

Eigenvalue

Condition

Constant

Violence

Disclosure

Index

Social
Support

1

4.685

1.000

.01

.01

.01

.01

.01

.01

.01

2

.778

2.454

.00

.04

.00

.43

.02

.03

.03

3

.530

2.974

.00

.23

.04

.05

.03

.03

.43

4

.423

3.330

.00

.07

.64

.04

.03

.05

.07

5

.355

3.632

.00

.62

.13

.19

.00

.00

.39

6

.126

6.106

.91

.01

.17

.26

.00

.19

.07

7

.103

6.738

.08

.01

.00

.02

.91

.70

.00
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To further explore this assumption, the researcher analyzed bivariate correlations of the
predictor variables to screen for strong relationships between variables. Pearson correlations
showed a moderate positive correlation between EIE scores and BDI scores in Data Set 1 (r =
.661, n = 146, p = .000). Pearson correlations showed a moderate correlation between EIE scores
and BDI scores in Data Set 2 (r = .719, n = 146, p = .000). This correlation between the two
variables indicates a potential violation of the assumption of multicollinearity although VIF and
tolerance values may indicate that the effect on the model is moderate to low. See Tables 9 and
10 for full correlational analysis of the predictor variables.
Table 9. Correlation Coefficients (Pearson Correlation) of Psychosocial Predictor Variables
for Data Set 1.
Violence
Stressors
Disclosure
Social
EIE
BDI
Support
Violence
Stressors

.243**

Disclosure

.171*

.092

Social
Support

-.185*

.106

-.020

EIE

.261**

.184*

.084

-.164*

BDI

.243**

.092

.049

-.193*

.661**

Note. *= (p ≤ .05); **= (p < .001)
Table 10. Correlation Coefficients (Pearson Correlation) of Psychosocial Predictor Variables
for Data Set 2.
Violence
Stressors
Disclosure
Social
EIE
BDI
Support
Violence
Stressors
Disclosure

.231**
.125

.021
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Social
Support

-.158

.079

-.017

EIE

.247**

.014

.067

-.234**

BDI

.210*

.032

.089

-.242**

.719**

Note. *= (p ≤ .05); **= (p < .001)
For research question two, a logistic regression model was utilized to estimate the
contribution of each predictor variable while simultaneously taking other predictor variables into
account and was tested across two groups, each composed of the smaller nonadherent group and
a random sample of the adherent group due to the unbalanced levels in the outcome variable.
This strategy was utilized in order to assess the generalizability of the model (Chan, 2004; Katz,
1999). The analyses were conducted in two steps into which BDI scores and stressors were
entered first followed by psychosocial variables of interest to identify the influence of depression
and stress before taking other possible risk factors for medication nonadherence into account.
The researcher conducted two two-step binary logistic regression analyses to determine if
the addition of disclosure of HIV status to family members, exposure to violence, social support,
and impulsivity improved the prediction of medication adherence over depression and stressors
experienced over the past year. The dependent variable for the analyses was medication
adherence, self-reported during an intake questionnaire. Stressors experienced in the past year
and depression scores as measured by the BDI were entered into the first block of the model as
control variables. Disclosure of HIV status to family members, impulsivity as measured by the
EIE, exposure to violence, and social support were entered into the second step of the model. See
Table for details on the full regression model. With regard to the full model, variables that were
statistically significant for both Data Set 1 and Data Set 2 are considered to robustly predict the
medication adherence outcomes (Cohen, Cohen, West, & Aiken, 2003).
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Logistic regression analyses were computed separately for each random sample of the
adherent group that was taken and will be referred to Data Set 1 and Data Set 2, respectively.
The omnibus test for Step 1 of the analyses yielded a nonsignificant Hosmer and Lemeshow test
for Data Set 1 ꭓ2(8) = 11.775, p > .05, and Data Set 2 ꭓ2(8) = 5.098, p > .05. This indicates that
the overall model fit of the psychosocial predictor variables was statistically reliable in
predicting medication adherence at the time of intake. The Negelkerke R2 for Step 1 variables
was .154 for Data Set 1 and for Data Set 2 was .120, indicating small effect sizes for the
associations between the selected psychosocial variables and medication adherence. In these
analyses, depression as measured by the BDI scores was a significant predictor of medication
adherence in both groups. The value of Exp(B) indicated that the odds of nonadherence to HIV
medication increased 8.9% for every 1 point increase in BDI scores in Data Set 1 [Exp(B) =
1.089, 95% CI =1.040-1.140] and by 8.6% in Data Set 2 [Exp(B) = 1.086, 95% CI = 1.0361.140].
In Step 2, selected psychosocial variables were entered into the regression analyses for
the two groups. The results of the Hosmer and Lemeshow test indicated that the overall model fit
of the six variables was statistically reliable in distinguishing between adherence or
nonadherence to ART at the time of intake evaluation in both Data Set 1 ꭓ2(8) = 6.345, p = .609,
and Data Set 2 ꭓ2(8) = 13.870, p = .085. The Nagelkerke R2 for Data Set 1 was .240 and for
Data Set 2 was .197, indicating that the full model explained 24% and 19% of the variation in the
outcome variable of Data Set 1 and Data Set 2, respectively. The inclusion of the psychosocial
variables in Step 2 resulted in an increase of 4.8% and 2.8%, respectively, in variance accounted
in the prediction of medication adherence beyond the variance accounted by Step 1 variables
only. The overall accuracy of the model to predict participants to be nonadherent at the time of
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intake evaluation was 69.2% in Data Set 1 and 65.8% in Data Set 2. In Data Set 1, the model
correctly classified 82.1% of participants who were adherent and 54.4% of participants who were
nonadherent. In Data Set 2, the model correctly classified 74.4% of participants who were
adherent and 55.9% of participants who were nonadherent. In these analyses, none of the
psychosocial factor variables were found to be a significant predictor of medication adherence in
both groups. However, impulsivity scores as measured by the EIE were found to be significantly
and positively related to medication nonadherence in Data Set 1 and exposure to violence was
found to be significantly and positively related to medication nonadherence in Data Set 2. For
complete statistics of binary logistic regression analyses for both groups, see Table 11 and 12.
Table 11. Binary Logistic Regression Coefficients of Data Set 1.
B

SE

Wald

df

Sig.

Exp(B)

Stressors

.071

.189

.142

1

.706

1.074

BDI

.038

.031

1.536

1

.215

1.039

EIE

.052

.026

3.973

1

.046

1.053

4.700

3

.195

Disclosure
No Disclosure
(Reference)

Support

.056

.462

.015

1

.904

1.058

-1.105

.795

1.930

1

.165

.331

.681

.588

1.341

1

.247

1.975

Violence

.266

.175

2.305

1

.129

1.305

Social Support

-.041

.062

.439

1

.508

.960

Constant

-1.316

.485

7.348

1

.007

.268

Rejection
Indifference
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Table 12. Binary Logistic Regression Coefficients of Data Set 2.
B

SE

Wald

df

Sig.

Exp(B)

Stressors

.011

.156

.005

1

.946

1.011

BDI

.035

.035

1.004

1

.316

1.036

EIE

.044

.028

2.416

1

.120

1.045

3.321

3

.345

Disclosure
No Disclosure
(Reference)

Support

.681

.455

2.237

1

.135

1.975

Rejection

-.469

.864

.294

1

.588

.626

Indifference

.323

.517

.390

1

.532

1.381

Violence

.358

.176

4.118

1

.042

1.431

Social Support

.001

.063

.000

1

.985

1.001

-1.768

.518

11.653

1

.001

.171

Constant

Summary
The results of the analyses provide varying levels of support for the research questions.
The first research question explored the relationship between the CD4 counts, violence and
social support. The second research question explored the relationship between various
psychosocial factors including exposure to violence, disclosure of HIV status to family members,
impulsivity, and social support with medication adherence when controlling for stressors
experienced during the past year and depression.
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CHAPTER FIVE
DISCUSSION
Chapter One provided an overview of the dissertation study including the problem
statement, the purpose of the study, and terms and definitions specific to the current study.
Chapter Two provided a review of the literature regarding HIV and AIDS in the world, the
United States, and Mexico as well as the relationship between HIV/AIDS and physical and
mental health. Chapter Three discussed the methodology utilized in the study which included the
research design, data screening, and data analysis procedures. Chapter Four presented the results
of the analyses. Chapter Five will provide a summary of the study as well as discuss the findings,
relevance of the findings to existing literature, implications, and limitations of the study.
Review of the Study
The aim of this study was to investigate the relationship between impulsivity, social
support, disclosure of HIV-positive status to family members, exposure to violence and
medication adherence. The purpose of this study was to add to the existing body of literature
regarding medication adherence among HIV-positive patients while highlighting psychosocial
factors which have the potential to impact adherence behaviors. Further, this study controlled for
depression and life stressors which have found to be predictive of adherence behaviors and poor
health behaviors in previous studies. The researcher hopes to support the mission of the Clínica
Especializada Condesa to establish streamlined care and best practices for the treatment of their
patients and to also support the need for counselor interventions in mental health programs
targeting the treatment of HIV-positive individuals.
The researcher conducted this study using an archival data set comprised of data
collected by researchers and medical staff at the Clínica Especializada Condesa of Mexico City.
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The final data set used for this dissertation included 601 participants from which two subsets
were created, each containing 146 participants. Ages of participants ranged from 17-67 years.
Participants completed intake questionnaires including questions regarding experiences of
violence throughout the lifetime, disclosure of HIV status to family members, social support, life
stressors experienced over the past year, and various other demographics including age, sexual
orientation, gender, borough of residence, employment status, and household information.
Participants also completed assessments regarding impulsivity, depression, substance use, and
physical and mental health functioning. Medical professionals recorded information derived
from laboratory blood samples such as CD4 counts and viral loads. Mental health professionals
recorded mental health diagnoses based on their clinical judgement using the DSM. The
researcher conducted bivariate correlations, a one-way ANOVA, and two hierarchical logistic
regressions to address the research questions.
Major Findings
The results of this study contribute to the extensive body of literature already in existence
in the field of HIV and AIDS medication adherence research. The findings include varying levels
of support for the research questions and hypotheses.
Research Question One
Bivariate correlations were conducted to investigate the relationships between CD4 cell
counts and social support and exposure to violence. Results varied in the relationships between
Data Set 1 and Data Set 2. In Data Set 1, the correlations showed a significant positive
correlation between violence and CD4 counts, indicating that as violence increased, CD4 counts
increased. The relationship between social support and CD4 was not statistically significant. In
Data Set 2, the analysis resulted in no statistically significant correlations between neither social
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support and CD4 nor violence and CD4. Therefore, researchers failed to reject the null
hypotheses for this analysis. The hypotheses predicted a positive relationship between CD4
counts and social support and negative relationship between CD4 counts and exposure to
violence.
A one-way ANOVA was conducted to examine the differences in CD4 counts between
disclosure groups (no disclosure, family accepted, family rejected, family indifferent). In both
Data Set 1 and Data Set 2, there were no significant differences between the four disclosure
groups indicating a failure to reject the null hypothesis.
Research Question Two
A sequential logistic regression was conducted to examine the relationship between
exposure to violence, impulsivity, social support, disclosure to family and medication adherence
when controlling for depression scores and stressors experienced within the past year. In support
of the research question, the model tested in both Groups One and Two were found to be
significant overall. While there were no factors which were found to be significant predictors of
medication adherence in both groups, impulsivity was found to be a significant predictor of
medication nonadherence in Data Set 1 and exposure to violence was found to be a significant
predictor of medication nonadherence in Data Set 2. Because neither variable was found to
robustly predict medication adherence (resulting in significance in both data sets), the researcher
failed to reject the null hypothesis for this research question. While the model controlled for
stressors and depression, stressors were not found to a be a significant predictor of medication
nonadherence in either group while depression was statistically significant in each group. While
neither impulsivity nor exposure to violence were significant across both groups, this
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information is noteworthy in the consideration of this population and in their treatment as
medication adherence has significant implications for HIV-positive patients.
Supportive Findings
This research suggests that both increased exposure to violence and higher scores on a
scale measuring impulsivity are predictive of increased probability of nonadherence to ART.
Medication adherence is vital for improving health outcomes with physicians emphasizing 8095% adherence for optimal health outcomes. However, physicians treating and researching HIV,
specifically, suggest 95-100% adherence to ART in order to prevent replication of HIV in the
bloodstream, to strengthen the functioning of the immune system, to lower the likelihood of
transmission, and to decrease the odds of developing drug resistant strains (National Institutes of
Health, 2017a; Osterberg & Blaschke, 2005; Smith et al., 2003).
Previous research has supported the association between violence and nonadherence to
medication among HIV-positive individuals. While the probability of medication nonadherence
significantly increased in only one of the subsets in this study, interpersonal violence has been
associated with increased mental health issues including PTSD and depression and has also been
associated with medication nonadherence in several studies found in the literature (Blashill et al.,
2011). The current study included participants who had experienced physical, psychological, and
emotional abuse. This is consistent with studies that have found higher levels of nonadherence to
ART among individuals who have experienced intimate partner violence, interpersonal violence,
sexual abuse, and verbal abuse (Campbell et al., 2016; Lopez et al, 2010; Pantalone et al., 2010;
Ramachandran et al., 2010). Important to mention is also the relationship between ethnic groups
and experiences of violence throughout the lifetime. While the sample in the study was an
international sample comprised entirely of Mexican nationals, in the United States it has been
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found that rates of childhood abuse seem to be higher in Latino MSM when compared to nonLatino MSM. This information is relevant especially since child abuse and violence are prevalent
among ethnic minorities, including Latino/as (Balsam et al., 2010; Feldman & Meyer, 2017).
This finding is important since research supports a connection between early childhood traumas
and risky-behaviors later in life.
Contradictory Findings
As was found during a review of the literature documented in Chapter Two of this
dissertation, literature regarding the study of medication adherence in HIV-positive populations
contains contradictory findings. This study did not find any significant results in the relationships
between medication adherence, social support, and disclosure of HIV status to family members.
Although there were no significant findings in this study, it is important to not dismiss these
factors. Non-significant findings could be due to the limitations discussed later in this section or
due to nuances of the specific population targeted for this investigation.
Social support has long been explored as a component in health outcomes for individuals
with chronic illness. For individuals with HIV and AIDS, social support and disclosure to family
and loved ones may be complexly interrelated. Individuals may disclose their HIV-positive
status to strengthen their relationships and to gain support from others but may also avoid doing
so due to fear of conflict and rejection (Chaudoir et al., 2011). Several studies have shown the
connection between disclosure of HIV status, decreased symptoms of depression, and improved
immune functioning (Hays et al., 1993; Sherman et al., 2000; Strachan et al., 2007). Yet
disclosure of HIV-positive status may increase stigma which has been related to psychological
distress and chronic anxiety, ultimately presenting a hinderance for medication adherence
(Guimarães et al., 2008; Sherr et al., 2008). In yet another study, researchers found that social
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support may in fact predict medication adherence but only when individuals have disclosed their
status to others (Waddell & Messeri, 2006). It is evident that researchers have found difficulties
establishing consistent connections between these constructs among HIV-positive populations as
the researcher has encountered in the current investigation.
Implications
The association between exposure to violence, impulsivity, and medication nonadherence
has important implications for conceptualizing and administering treatment to individuals with
HIV and AIDS. Furthermore, taking into consideration previous research and the factors
examined in the current study, there are implications which must be considered for HIV and
AIDS treatment, counselors working in healthcare settings, and for teaching and counselor
education programs as our healthcare and treatment delivery system continue to move toward an
environment that embraces streamlined interprofessional collaboration and integrative care.
Implications for HIV and AIDS Treatment
In their 2017 report on HIV drug resistance, the World Health Organization discusses the
global target 90-90-90 which have been widely adopted. This target reflects the efforts of the
global community to achieve the diagnosis of 90% of all people with HIV infections, providing
treatment to 90% of the individuals who have been diagnosed, and guaranteeing that 90% of
those receiving treatment reach virologic suppression by the year 2020. As of the end of 2016,
those numbers were 70%, 77%, and 82%, respectively (World Health Organization, 2017). The
World Health Organization has emphasized the importance of addressing HIV drug resistance
and has guided 26 countries in implementing HIV drug resistance surveillance surveys. One of
these countries is Mexico which has seen more than 10% pretreatment non-nucleoside reversetranscriptase inhibitor (NNRTI) resistance in three of six surveys (World Health Organization,
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2017). NNRTIs are considered first line of treatment of individuals with HIV, as such, drug
resistance to these medications may come with a great cost including difficulty achieving viral
suppression, increased chances of virologic failure or death, increased likelihood of
discontinuing treatment, and increased probability of developing new HIV drug resistant
mutations (World Health Organization, 2017). Suboptimal adherence to medication can increase
the likelihood of developing drug resistant strains and virologic failure, also increasing the
chances of transmitting a drug resistant strain to others (World Health Organization, 2017).
Medication adherence in HIV and AIDS treatment is an urgent public health matter and must be
addressed in clinics and treatment facilities worldwide.
Studies have focused on the causes of virologic failure and drug resistance from a
medical standpoint but have also begun to increasingly identify psychological, social, and
economic factors which influence adherence behaviors. Studies have been conducted in countries
across the globe to help better understand these psychosocial factors influencing adherence and
have identified similar trends among low- and middle- income countries. Substance use, cost of
travel and access to transportation, adverse side-effects, lack of reminder tools, and perceived
social acceptance have all been identified as factors influencing adherence (Shigdel, Klouman,
Bhandari, & Ahmed, 2014). In addition to these aforementioned factors, others may include cost
of medications, age, sex and gender, education, occupation, household composition, physical
disabilities, self-esteem and motivation, mental health conditions, social status and social
support, homelessness, incarceration, and cultural models of health and disease (Castro, 2005).
The clinic in Mexico has been at the forefront of treatment in the country and has
included many items on their intake questionnaires addressing factors and behaviors such as
those mentioned above: social support, mental health conditions, social support, living situation
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and household composition, and occupation. The results of this study support the continued
screening for factors associated with medication adherence and nonadherence in order to best
understand the trends in specific populations as well as to best predict who will be more likely to
not adhere for early interventions to take place. This will help to guide the fine-tuning of intake
processes, evaluations, and assessments used to garner information from clients. This also
supports the need for streamlined care with professionals from various backgrounds working
collaboratively in order to create approaches that are holistic in nature and address the wholeness
of an individual and their systems.
Implications for Counselors in Health Care Settings
Nonadherence to medications is associated with costs of over 1 billion dollars in the
United States yearly with estimates of 33-69% of hospital stays attributed to poor adherence to
medications (Palacio, Garay, Langer, Taylor, Wood, & Tamariz, 2016). This overwhelming
statistic indicates a major problem in public health and signal a need for improved quality of care
and intervention. Recently, there has been a trend toward integrating services in the delivery of
healthcare. Integrative care has been increasingly recognized as essential to improving the
quality of care to individuals seeking treatment (Shallcross, 2013). When considering the
treatment of HIV and AIDS patients, counselors could play a crucial role in delivering treatment
which is holistic and is targeted toward achieving best outcomes. Many of the factors influencing
adherence to HIV medication are issues which counselors are trained to handle throughout their
education. HIV and AIDS impacts many systems in the individual’s life including social,
psychological, and biological aspects. Counselors today are dealing with some of the most
complex issues which face our society, making counselors prepared to deal with the array of
complexities which HIV and AIDS patients face from the time of diagnosis (Quealy-Berge &
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Caldwell, 2004). Counselors are well-versed in communication skills which are essential to the
practice of healthcare in order to convey compassion and provide care in an ethical manner
which focuses on the client-provider relationship. Research has shown that effective
communication with emphasis on compassion and ethical practice leads to improved health
outcomes, better quality of care, and increased patient and clinician satisfaction (Rider at al.,
2014). This supports the need for counselors in integrated care since counselors are trained to
form supportive and affirmative working alliances with their clients and are trained to provide
empathic responses, show compassion, and be aware of biological, psychological, and social
domains of a client’s experiences (Bowen & Moore, 2014). The International Charter for Human
Values in Healthcare have identified fundamental values essential to best practices including
empathy, genuineness, acceptance, self-awareness, multicultural competence, attention to
wellness, which are qualities identified as important characteristics for workers in the human
services (International Charter for Human Values in Healthcare, 2011; Neukrug, 2017).
While counseling is a normal part of HIV testing, brief counseling interventions
throughout the course of treatment are not currently a standard of treatment especially not with a
focus on medication adherence. Several studies have been documented which provide
information on the impact of counseling interventions on medication adherence in HIV-positive
samples. One study piloted an adherence program consisting of one-on-one counseling which
targeted patients starting ART for the first time. These patients were to attend two counseling
sessions before initiating their ART regimen which focused on education on HIV and AIDS,
resistance, and therapeutic failure, evaluation of family support, and identification of the barriers
and strategies related to adherence (Winter, Halpern, Brozovich, & Neu, 2014). Researchers
discovered that individuals who received the counseling intervention had improved rates of
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adherence when compared to those who did not receive the counseling intervention. Adherence
in this study was measured by appointment attendance; however, attendance was associated with
an increase in CD4 counts which is often an indicator of adherence to ART. Another study
examined brief medication adherence strategies implemented by pharmacists which emphasized
the need for personalized adherence strategies based on the specific patient’s lifestyle and the
need for providing follow-up care for individuals who have been identified as nonadherent to
their medications (Mangan, Fowers, & Lengel, 2012). Yet another study examined the
effectiveness of motivational interviewing techniques on an HIV-positive sample in terms of
adherence to ART. Motivational interviewing, a skill taught in most counseling programs, is an
approach which utilizes cognitive behavioral techniques aiming to help individuals express and
work through their ambivalence to address specific behaviors while encouraging clients to selfauthorize and create solutions to their problems (Miller & Rollnick, 2012; Palacio et al., 2016).
Researchers found that motivational interviewing interventions improved medication adherence
although simultaneously acknowledged that improving adherence is difficult due to the
complexity of its determinants and the inconsistent definitions of adherence existing in the
literature. While research has supported the effectiveness of motivational interviewing in primary
care and community clinics in the United States, there are inconsistent training methods and
modes of delivery documented as well as duration of time exposed to motivational interviewing
interventions and outcome measures (Palacio et al., 2016). This supports the need for further
research in this area, establishment of best practices in terms of training and utilization of
intervention programs targeting medication adherence so there is a standard of measurement
across healthcare settings. Additionally, since counselors are skilled in motivational interviewing
and are trained to work with client ambivalence, it could be a seamless opportunity for
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counselors to play an integral role in achieving the target for optimal medication adherence
among HIV and AIDS patients. This could involve counselors providing coaching and training to
physicians and other medical staff or to be the leaders in developing and implementing
counseling interventions with these aims in mind.
While counselors in healthcare are valuable assets to the treatment team, counselors may
face certain challenges related specifically to their interactions with professionals from other
disciplines. Interprofessional collaboration may present its challenges in healthcare settings yet
remains a vital function especially in the treatment of HIV and AIDS which can be complex and
involve many aspects of identity and impact the interlocking systems in which an individual’s
problems exist.
In the clinic in Mexico, there are several departments with a variety of healthcare
professionals attempting to work together to facilitate streamlined holistic care of HIV and AIDS
patients. Mental health professionals are part of this team. While the counselor identity is not yet
well-established in Mexico as it is in the United States, the counseling profession continues to
struggle in the United States to establish a professional identity which is cohesive (Mellin, Hunt,
& Nichols, 2010). This lack of shared identity may exacerbate the challenges faced by
counselors when faced with interprofessional collaboration since there are many overlapping
characteristics with other helping professions. Despite these challenges, interprofessional work is
increasingly supported as an optimal approach to healthcare service delivery requiring the
expertise of professionals from multiple disciplines to address complex issues. Scholars
including McAuliffe and Eriksen (1999) argue that counseling can be readily differentiated from
other helping professions by its emphasis on development, prevention, and wellness, all
necessary components of treatment in interprofessional settings.
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When considering the role of counselors working with HIV and AIDS patients, there is a
complex interplay of systems which are impacted in the individual’s life guided by their
diagnoses, symptoms, medication regimen, psychological processes, and resulting in issues with
relationships, occupation, finances, etc. While counseling has traditionally been seen as a
profession which focuses on the individual, this implicates the need for greater emphasis on
systems theory in counseling programs and increased focus on ecological and contextual models
highlighting the interplay of sociocultural forces (Arredondo, Shealy, Neale, & Winfrey, 2004).
In interprofessional healthcare environments, counselors must adapt to dynamics of the
workplace and the language and pace of physicians while also remaining confident in their
knowledge and craft.
Implications for Counselor Education
Counselor education programs could benefit from implementing more coursework
focused on integrative care which aims to increase knowledge of medications not only for
psychiatric issues but also for HIV and other common ailments (Arredondo et al., 2004). Mellin
et al. (2010) also suggest increased focus on positive psychology, solution-focused approaches,
cognitive behavioral therapy, brief therapy, stress management, relaxation techniques, family
systems work, motivational interviewing, strength-based approaches, and wellness-based
approaches. In considering the immense impact of HIV and AIDS on the individual and the
individual’s systems and relationships, these aforementioned approaches would be optimal in the
development of strategies targeting adherence counseling programs as well as in facilitating
interprofessional collaboration. Offering students opportunities to hone these skills during their
programs using hands-on experiences through mock simulations, practicums and internships, and
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scholarship opportunities is not only ideal but vital as our society shifts toward new models of
care.
Teaching. As treatment models continue to shift toward more holistic, integrative, and
interprofessional approaches, counseling students would benefit from further training in
ecological and systems theories in order to create a stronger thread throughout counseling
programs which emphasizes collaborative efforts needed to achieve optimal service delivery.
Since counselors are increasingly entering positions requiring them to work in healthcare settings
and dealing with issues relating to chronic illnesses including HIV and AIDS, counselor
educators might consider the development of specialized tracks within their counseling programs
which not only emphasize systemic models but provide coursework aimed to prepare students
for addressing health concerns, the mind-body connection, holistic and alternative forms of
medical treatment, and integrative care. This may require a shift in the traditional views of
counseling and counselor education.
Millen, Hunt, & Nichols (2011) conducted a qualitative study on counselor professional
identity which revealed several stereotypes that exist within the counseling field regarding
distinctions between the helping professions of social work, psychology, and counseling. The
findings indicated that several of the participants believed that counseling was more focused on
the individual at a microlevel, on wellness, and on personal growth rather than systemic issues,
global issues of functioning, testing and assessment, and case management which were seen as
more characteristic of social work and psychology. These views are problematic as counseling
does require a systemic focus for many of the complex sociocultural issues clients will present
during a session. Considering a complex issue such as HIV and AIDS, counselor educators have
the responsibility for underlining the value of systems thinking and how these approaches can be
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used to conceptualize work with individuals living with HIV and AIDS and other chronic
illnesses including the manner in which the illnesses impact clients’ worldviews and contextual
experiences within various interlocking systems in their lives. Counselor educators have the
responsibility to impart with counseling trainees the importance of counseling work in health
care settings and to stress that counselors do belong alongside doctors, nurses, and social
workers, for example. To effectively address integrative care models, counselor educators should
include specific topics in their coursework and lesson plans including but not limited to the
context of integrative mental health care, evaluating a client from an integrative perspective,
recommending treatment and making referrals, and clinical problem solving (Lake, 2009).
Having more practice with these concepts throughout the course of their education will better
prepare students to understand the complexities of issues such as medication adherence and the
importance of a systemic approach to dealing with the issue. Counselor educators can achieve
this through the use of case vignettes, guest lecturers, and including options for integrative care
practicum and internship experiences.
Supervision. A predominant developmental model often used in clinical supervision is
the Integrated Developmental Model (IDM) (Stoltenberg, McNeill, & Delworth, 1998). This
model is based on the notion that supervisees go through phases, or levels, of development in
their work. In each of these levels, the focus is on the motivation of the supervisee, the autonomy
of the supervisee, and the awareness of the supervisee. Supervisors can use this practical model
to assess the developmental level of the supervisee in order to accurately support, challenge, and
promote growth with appropriate supervision interventions and strategies. A clear strength of
this model is that it focuses on the developmental level of the supervisee. This helps the
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supervisor to conceptualize the supervision process and relationship as well as to be sure to use
the most appropriate techniques to facilitate professional growth and client welfare.
Using the IDM to conceptualize work with a supervisee who has clients living with HIV
and AIDS is helpful in creating a framework for training counselors in integrative care settings.
As counseling trainees embark on their practicum experience, it is essential for supervisors to
share knowledge regarding systemic approaches to illness and coping and to work with the
supervisee to encourage the understanding of how a diagnosis of HIV or AIDS can impact not
only a person’s health but also their worldview, social interactions, overall psychological
wellbeing, and health behaviors such as medication adherence. Supervisees early on in their
clinical experiences tend to be limited in their self-awareness and are unsure of their abilities in
the therapeutic relationship. Supervisors can encourage supervisees to develop their sense of
self-efficacy by arming the supervisee with information preparing them to assess for global
issues of functioning and risk factors such as substance use which could be indicators of risky
health behaviors, including nonadherence to medication.
As supervisees continue to gain confidence in their abilities, clinical work will continue
to become more challenging as they gain new responsibilities. Supervisors should encourage
supervisees to become more autonomous and assist them as they experience internal conflicts or
resistance. These factors may be especially important for counselors working in interprofessional
healthcare settings where they may experience difficulties working with professionals from other
backgrounds such as medicine and social work. Supervisors are an integral part of a trainee’s
development and can support supervisees while challenging them for their growth. As trainees
work with populations such as HIV-positive individuals who will challenge their knowledge of
interlocking systems, supervisors have the responsibility to coach and educate yet also ensure
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proper multicultural competencies and skills relating to evaluation and assessment regarding risk
factors and monitoring of health behaviors impacting overall functioning.
Limitations
There are several limitations to this study which should be given consideration when
interpreting the results of the current investigation. First, there are methodological concerns.
Using logistic regression limits the outcome to using a categorical variable. Additionally, logistic
regression tends to be vulnerable to overconfidence so the model could appear to have more
predictive power than it actually does. The sample size utilized for the study was small for a
logistic regression analysis. The sample size used was the minimum sample size needed to
achieve power according to an a priori G*Power analysis. Furthermore, the sample was reduced
significantly from its original size. The original data set included data from approximately 4,800
patients of the clinic which was reduced to a sample of 601 participants. This occurred due to the
sampling process which was based on inclusion criteria. This was also due to excluding
participants based on the assessments included as part of the intake evaluation at the clinic which
had missing information that could not be imputed. After reducing the data set to 601, the
distribution of cases among the two groups of the dependent variable medication adherence was
significantly skewed. In order to account for this skewness, the researcher obtained two random
samples from the adherent group which was larger and merged each of these samples with the
nonadherent participants to form two separate subsets or samples. This strategy was used in
attempts to best maintain the integrity of the sample, however, considering all aforementioned
limitations, it is certainly a concern in that it may not capture the true essence of the population.
A similar issue exists within the distribution of cases among the categorical independent variable
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representing disclosure to family members of HIV-status. Cases were not evenly distributed
among the four groups which may also present a limitation for the current analysis.
Regarding the independent variable representing exposure to violence, during the intake
process, participants reported their experiences of abuse according to four different categories
throughout the lifetime. This information was transformed into an ordinal variable which
indicated how many types of these categories had been experienced throughout the lifetime
instead of which specific types. This may be considered a limitation since there may be clear
differences between groups in terms of their adherence behaviors. Additionally, information that
was collected during the intake process regarding these experiences was intentionally excluded
from the model but could have been relevant. This information pertained to stages of life during
which the types of abuse or violence were experienced and could have added a richness to the
study: childhood, adolescence, or adulthood.
Another limitation of the study was the use of an archival data set. The researcher
attempted to immerse himself in the environment in which the data was collected to familiarize
himself with the intake process, the data collection process, and the significance of the
information being collected. However, the researcher had no control over the data collection
process which could present potential limitations such as representation of targeted population,
accuracy of information, and accuracy of clinical diagnoses. Many participants did not complete
specific assessments which presented an issue for the researcher when conducting analyses
resulting in a large number of cases excluded from the study.
Lastly, a limitation to be considered relates to the diagnoses of the participants.
Participants included in the study represented a wide range of psychiatric diagnoses each with
varying levels of representation. Additionally, participants with co-occurring substance abuse
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issues were kept in the sample as long as they also had a primary diagnosis of a psychiatric
disorder. This has the potential to have impacted the outcomes of the analyses. Causality can not
be inferred due to the non-experimental nature of this study.
Implications for Future Research
Considering the results of this study and associated limitations, there are several
implications for further research. First, future studies should optimize sample size in order to
achieve a larger representation of the population. This will provide a stronger model through
which to examine the relationships between the variables. Next, this study was a cross-sectional
investigation using information from one point in time. In the future, repeated measures or
longitudinal investigations may be beneficial to better understand the trends that exist within a
specific population and will provide a more comprehensive understanding of the variables of
focus. Additionally, the research may benefit from the examination of adverse childhood
experiences and their impact on medication adherence to better understand if there is an
association between the two. By continuing to improve models used on this population, best
practices could be developed and implemented not only in the clinic in Mexico City, but could
be tested in other clinics in the area, other clinics in the country, and outside of the country.
Conclusion
This study investigated the relationship between depression, stressors, disclosure to
family members of HIV status, social support, impulsivity, and exposure to abuse on medication
adherence. The purpose of this study was to add to the existing body of literature regarding the
determinants of medication adherence to ART among HIV-positive individuals. Findings from
this study suggest that both exposure to abuse and impulsivity may negatively impact medication
adherence, however, findings were not consistent across the analyses in the study possible due to
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sample size and uneven groups in several independent variables and the dependent variable.
Future research can focus on improving the validity of the study by increasing the sample size
and ensuring that groups are adequately distributed among the variables. This study emphasizes
the importance of interprofessional collaboration, early prevention and detection of medication
nonadherence, and the role of counselors in delivering services to address complex issues in
healthcare, specifically HIV and AIDS.
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CHAPTER 6
MANUSCRIPT
Abstract
This dissertation examined the relationships among disclosure, social support, exposure to
violence, impulsivity, depression, stressors, and medication adherence, using a correlational
design and a sequential logistic regression. The researcher used two samples of 146 from an
archival data set of participants to create two subsets of the data (Data Set 1 & Data Set 2). These
participants had been diagnosed with a mental illness and were prescribed a medication regimen
for HIV treatment at the time of intake in a specialized clinic in Mexico City. Archival data was
obtained through a demographic intake questionnaire and the use of valid and reliable
instruments adapted for the specific population: State Impulsivity Scale (SIS) and the Beck
Depression Inventory (BDI). Data analysis included descriptive statistics related to population
demographics, bivariate correlations, and a sequential logistic regression based on existing
literature on HIV/AIDS, medication adherence, and a theoretical model of stress and coping.
Results of the analyses indicated that impulsivity was found to be predictive of medication
nonadherence in Data Set 1 and exposure to violence was found to be predictive of medication
nonadherence in Data Set 2. However, since both were not found to be significant across both
subsets of the data, the variables could not be considered to robustly predict medication
nonadherence in this study.
Introduction
Medication adherence is crucial for improving health outcomes in individuals with HIV
and AIDS. However, research has shown that patients prescribed antiretroviral medications do
not always adhere at optimal levels. Physicians treating HIV patients suggest 95%-100%
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adherence to antiretroviral medication to hinder the replication of HIV in the bloodstream,
strengthen immune functioning, lower likelihood of transmission, and decrease the chances of
developing drug resistance (National Institutes of Health, 2017a; Smith, Rublein, Marcus, Brock,
& Chesney, 2003). As the level of adherence decreases, the likelihood of virologic failure
increases. Virologic failure and drug resistance can develop when adherence is not at optimal
levels, increasing the chances that an individual could develop and transmit new drug-resistant
strains of the virus in which HIV medications may no longer be effective. Adherence to
medication is influenced by a variety of factors including the medication regimen itself, the
patient-provider relationship, and psychosocial, behavioral, and structural barriers (National
Institutes of Health, 2017). For this reason, continued research on the topic is vital to the
understanding of the factors contributing to medication adherence in diverse populations to
improve interventions, integrative care, and health outcomes.
For this study, the problem was examined in a population of HIV-positive individuals in
Mexico City. While the prevalence of HIV and AIDS is lower in Mexico in comparison to other
Latin American nations, there has been an increase in the amount of detected drug resistant
strains of HIV in recent years signaling a significant concern for public health and medical
professionals. The clinic from which the data are derived is one of the largest HIV-centered
treatment facilities in Mexico and Latin America with a program targeting specialized treatment
of HIV and AIDS patients who have been diagnosed with mental health disorders. Being that
Mexico City is the largest metropolis in Latin America, it is an ideal setting to gain an
understanding of the multitude of dynamics impacting HIV and AIDS treatment, specifically
related to medication adherence. Typically thought of from a medical perspective, medication
adherence is a topic most often discussed by physicians. While it is essential for physicians to be
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involved in the screening of medication adherence, it is also essential for the involvement of
other professionals, including counselors and related mental health specialists who may be more
attuned to psychosocial and mental health factors impacting the lives of patients. As Western
medicine continues to move toward an integrative care model, it is crucial to create effective
treatment models in HIV/AIDS-specialized clinics and treatment centers to foster
interprofessional collaboration, streamlined communication and treatment for optimized health
outcomes.
The purpose of this study was to examine the relationships among psychosocial factors,
immune functioning, and medication adherence in HIV-positive individuals. The archival data
set which was analyzed in this dissertation has never been analyzed before, creating a unique
opportunity to explore phenomena occurring in this population. The researcher intended to
investigate these aforementioned relationships to cultivate new knowledge for the clinic in
Mexico City and to contribute to ongoing research regarding medication adherence in public
health. Additionally, it is the hope of both this researcher and the clinic staff that this research
may highlight the need for further research on this topic, targeted efforts for improving
medication adherence, enhanced screening for risk factors for nonadherence, and improved
interventions for HIV patients using integrative care models where collaboration across the
health professions is the norm. Based on prior literature, the following research questions guided
this study:
1. What are the relationships between CD4 counts, violence, disclosure, and social support?
2. To what extent do disclosure, social support, impulsivity, and exposure to violence
predict medication adherence in HIV-positive individuals after controlling for depression
and major stressors experienced within the past year?
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Literature Review
Psychiatric morbidity was detected early in the HIV epidemic. As such, HIV has long
been associated with psychological distress including anxiety, depression, and other general
negative mental health outcomes as it is a disease which significantly impacts all aspects of
wellbeing (Folkman, 1993; Stewart et al., 2012; Choi et al., 2016). A study conducted in the
United States in the 90s showed that 48% of adults receiving care for HIV showed signs of at
least one psychiatric disorder on screenings within the previous year (Bing et al., 2001). This
study included 2,864 who were administered a screening assessment for multiple psychiatric
disorders including major depression, dysthymia, generalized anxiety disorder, and panic
disorder. Researchers in the Netherlands studied the relationships between coping styles, goal
disturbances, and psychological distress in HIV-positive individuals. In a sample of 43
participants from ages 23-63 who were at different stages of disease progression, the researchers
found that disturbances of daily events, or goal disturbance, was directly related to higher levels
of psychological distress. It was suggested from this study that these daily disturbances could
result from HIV and associated symptoms as well as the medical regimen or associated sideeffects (Van Der Veek, Kraaij, Kopeen, Garnefski, & Joekes, 2007). A more recent study
conducted in 2013 used a community sample of 197 people living with HIV/AIDS to examine
the impacts of societal stigma and internalized stigma on psychological wellbeing. Researchers
concluded that stigma associated with HIV plays a central role in the development of depression
and anxiety, especially in individuals who display pessimistic coping styles (Herek, Saha, &
Burack, 2013). In 2014, a study conducted using a representative community sample in rural
South Carolina assessed perceived stress, mood profile, and symptom-related distress to better
understand the association between symptom distress and psychological factors among HIV-
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positive persons. Participants were 18 years of age or older and were not taking medications to
treat depression or anxiety at the time of the study. The results showed that the strongest
correlations were between fatigue and symptom frequency and fatigue and symptom distress
(Jaggers, Dudgeon, Burgess, Phillips, Blair, & Hand, 2014). These findings are important in their
contribution to the literature since previous research has shown that fatigue is one of the most
common symptoms reported by persons living with HIV/AIDS. Several studies in the early
2000s support these findings identifying strong correlations between fatigue and multiple
measures of psychological distress and psychological distress, decrease in routine activities, and
physical functioning due to fatigue (Norval, 2004; Phillips et al., 2004; Henderson, Safa,
Easterbrook, & Hotopf, 2005; Hand, Phillips, & Dudgeon, 2006). Additionally, psychological
distress has been detected in higher levels in persons living with HIV who report experiencing
fatigue (Breitbart, McDonald, Rosenfeld, Monkman, & Passik, 1998). These combined results
show that there is a long-known history of the correlation between psychiatric distress and
HIV/AIDS diagnoses with strong support for the consequences of long-term distress leading to
negative health behaviors and decreased quality of life.
Psychological stress, dejection, and distress are pervasive with chronic illness. Common
sources of psychological distress in individuals with chronic illness are the ambiguity regarding
one’s future state of health, instability of symptoms or physical discomfort, and the impact on the
individual’s family and relationships (Holder-Perkins & Akman, 2006). Studies of individuals
diagnosed with severe illness have labeled several key themes for preserving emotional stability
including a search for meaning, attempts to gain control over illness, and attempts to enhance
self-esteem (Holder-Perkins & Akman, 2006).
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The immediate psychological impact following an HIV diagnosis is commonly one of
acute distress manifested as depressed mood, anger, shock, anxiety, tension, perceived stress, and
overwhelming intrusive thoughts. The prevalence of these symptoms has not yet been
determined. While these symptoms are typically mild, they can be severe and even crippling to
the degree that they may meet the criteria for a diagnosable psychiatric disorder (Holder-Perkins
& Akman, 2006).
Depression and HIV
Depression constitutes the second most frequently observed illness worldwide. In the
United States, depression is observed in about 6.7% of the population (National Institute of
Mental Health, 2017). Among chronically ill persons in the United States, the rate of depression
is higher at 9.5% with patients who suffer from HIV infection or AIDS experiencing a rate of
depression which is significantly higher, ranging from 20-40% (U.S. Department of Veterans
Affairs, 2018). Additionally, suicide ideation tends to be present among two thirds of patients
who are depressed and the rate of suicide among depressed patients is 10-15% (Ruiz, 2006).
Several factors that put patients with HIV/AIDS at higher risk for depression are those
with exposure to chronic stress, inadequate social support, and passive coping styles. Other
factors which contribute to higher risk of developing depression are nondisclosure of HIV status,
multiple losses, advanced illness, alcoholism, substance use, female gender, and personal or
family history of suicide attempts, mood disorders, and anxiety disorders (Ruiz, 2006). The most
common complications of chronic medical illness involve depressive symptoms. Studies have
shown that depression has a damaging effect on patients’ quality of life, adherence to treatment,
and treatment outcomes (Treisman & Angelino, 2004). Despite compelling research, depressive
conditions remain underrecognized, underdiagnosed, and undertreated in medical clinics,
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especially in treatment centers focused on HIV/AIDS. Depression should be a major concern for
HIV/AIDS researchers and treatment providers as it can impact patient attitudes toward
treatment. Individuals with depression often care less about their own safety, act impulsively,
and have perpetual feelings of hopelessness (Treisman & Angelino, 2004).
Studies have shown an increased prevalence of HIV among individuals who have mental
health problems and an elevated prevalence of depression and other mental health conditions
across individuals who are HIV seropositive (Anderson & Weatherburn, 2004; Bing et al., 2001;
WHO, 2008). Researchers exploring the association between disease progression and depression
in both men and women found that individuals with HIV who exhibited depressive symptoms
were nearly 2 times more at risk of mortality than individuals who did not (Ickovics et al., 2001;
Mayne, Vittinghoff, Chesney, Barrett, & Coates, 1996). While an abundance of research has
established the connection between physical illness and depression, it has been challenging to
establish the causal pathway between the two. Depression can affect immune function; however,
it may also be the outcome of disease progression or negative life events (Pence et al., 2006).
Adherence and HIV
Adherence to medication can be defined as the extent to which a person’s behavior
matches the health care regimen prescribed by a medical professional. Importantly, this treatment
regimen should be agreed upon by the healthcare professional and the patient. Adherence
involves taking medication correctly, at the right time, with the proper frequency, and at the
accurate dosage (Brown & Bussell, 2011; Cramer et al., 2008). Medication adherence is vital for
improving health outcomes with physicians emphasizing 80%-95% adherence for optimal
trajectory of health outcomes (Osterberg & Blaschke, 2005). However, physicians researching
and treating HIV patients suggest 95%-100% adherence to antiretroviral medication to impede
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the replication of HIV in the bloodstream, strengthen immune functioning, lower likelihood of
transmission, and decrease the chances of developing drug resistance (National Institutes of
Health, 2017; Smith, Rublein, Marcus, Brock, & Chesney, 2003). While many HIV regimens
currently include a combination of medications to effectively treat individuals, two main types of
antiretroviral medications used are protease inhibitors and non-nucleoside reverse transcriptase
inhibitors. Research has shown that in samples of HIV-positive individuals adhering 90% of the
time to each of these classes of drugs, 55% of patients taking protease inhibitors and less than
10% taking non-nucleoside reverse transcriptase inhibitors experienced virologic failure
(Paterson et al., 2000; Viswanathan, et al., 2016). As the level of adherence decreases, the
likelihood of virologic failure will increase. Virologic failure is defined as a level of greater than
400 copies/mL of HIV in the bloodstream than the last clinic visit. Virologic failure and drug
resistance can develop when adherence is not at optimal levels, increasing the chances that an
individual could develop and transmit new drug-resistant strains of the virus in which HIV
medications may no longer be effective (National Institutes of Health, 2017b). Factors to
consider which may impact adherence in an individual are side effects, high cost of treatment,
lack of access to treatment, poor communication between provider and patient, unstable living
situation, alcohol or drug use, fear of disclosure, and illness or depression (National Institutes of
Health, 2017b; Cutler & Everrett, 2010; Simpson, 2006). In research conducted examining
correlations between race and medication adherence, researchers found that Hispanics and
African Americans have lower medication adherence rates in comparison with Caucasians
(Manias & Williams, 2010; Simpson, 2006).
Depression, Adherence, and HIV
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Depression and psychological distress have been well-documented in research as
contributing factors to negative health outcomes and poor adherence to medical treatments
(DiMatteo et al., 2000; Manning & Wells, K. B., 1992). Grenard et al. (2011) conducted a metaanalysis of 31 studies including over 18,000 participants to explore the relationship between
depression and medication adherence in the treatment of chronic illnesses in the United States.
Depressed patients were found to be 1.76 times more likely to be nonadherent to treatment
regimens than their non-depressed counterparts. In a review of the literature regarding Latino
HIV-positive men who have sex with men (MSM), increased levels of depression were
associated with increased frequency of high-risk sexual behaviors, implicating increased risk for
transmission of HIV, especially if those individuals were nonadherent (Gonzales, Hendriksen,
Collins, Durán, & Safren, 2009). In the United States, where Latinos are less likely to seek help
and receive proper treatment for mental illness, including depression, the risk for nonadherence
is increased (Gonzales, Hendriksen, Collins, Durán, & Safren, 2009). Numerous studies focusing
on HIV-positive men and adherence behaviors have supported the relationship between
depression and nonadherence to treatment underscoring the importance for effective and
informed clinical practice, preventive measures, and intervention (Blashill, Perry, & Safren,
2011; Gonzalez et al., 2004).
In Mexico, researchers have found depression to be prevalent among persons living with
HIV at similar rates to studies conducted in the United States (Caballero-Suarez, RodriguezEstrada, Candela-Iglesias, and Reyes-Teran, 2017). In northern Mexico, a study was conducted
with 64 participants where researchers examined the relationships between stress levels,
depression, and adherence to medication regimen. The results of the study showed that high
levels of stress and depression tend to occur simultaneously and contribute to poor adherence to
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medical treatment (Piña Lopez, Dávila Tapia, Sánchez-Sosa, Togawa, & Cázares Robles, 2008).
This has strong implications for assessment, early intervention and treatment, and maintenance
for HIV/AIDS patients as poor adherence to antiretroviral medication may result in proliferation
of HIV in the body as well as drug resistance. Pérez-Salgado, Compean-Dardón, & OrtizHernández (2016), obtained a sample of persons living with HIV from various clinics in Mexico
to study the relationship between food insecurity and adherence to HIV medications. From the
sample in Mexico City, it was noted that psychological distress best explained the relationship
between food insecurity and medication adherence. While food insecurity is associated with poor
mental health and poor adherence to treatment, it is also important to note that poor mental
health status has generally been associated with nonadherence. That is to say, deficient
psychological distress is another potential mechanism by which food insecurity would be
associated with nonadherence to medication.
Social Support and Disclosure of HIV-positive Status
Social support has long been explored as a key component in health outcomes for
individuals with chronic illness. For individuals with HIV/AIDS, disclosure of one’s status is a
unique process complexly connected to social support and influenced by factors such as race,
society, perception of stigma, family, children, sex partners, and mental health (Rotzinger et al.,
2016). Chaudoir, Fisher, & Simoni (2011) reviewed literature on disclosure and its relationship
to social support, collaborating to establish a model which addresses the gaps in research on this
topic. Their Disclosure Processes Model aims to provide a framework to conceptualize the
process of disclosure for people living with HIV/AIDS. These researchers emphasize that
previously developed models have focused on the identification of factors leading to disclosure
such as disease progression, perceived consequences, and levels of relationship intimacy (Bairan
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et al., 2007; Serovich, 2001; Serovich, Lim, & Mason, 2008) rather than the outcomes of
disclosure. The creators of the newer processes model argue that disclosure has implications for
both individual health and public health by having positive influences on overall health and
health behaviors. For example, individuals living with HIV/AIDS might attain greater social
support after disclosure encouraging openness about status and a change in behaviors and
perceptions impacting one’s health (Kalichman, DiMarco, Austin, Luke, & Difonzo, 2003).
Individuals may disclose their HIV-positive status to strengthen their relationships and to gain
social support from others, however, individuals may also avoid disclosure of their positive
status due to fear conflict and social rejection (Chaudoir, Fisher, & Simoni, 2011). Disclosure
has the potential to impact health outcomes as it can result in more social support, the mitigation
of negative psychological effects of suppression, and overall improved psychological wellbeing
(Strachan, Bennett, Russo, & Roy-Byrne, 2007). In a study conducted by Hays, McKusick,
Pollack, & Hilliard (1993), researchers found that HIV-positive MSM who disclosed their status
to their supports reported lower depression at a one-year follow-up. Strachan et al., (2007)
conducted a longitudinal study in which they found increased improved immune functioning
predicted by disclosure of HIV status among a group of HIV-positive men and women in the
United States. This research was supported by previous research conducted by Sherman,
Bonanno, Wiener, & Battles (2000) which found increases in immune functioning among
children who disclosed their HIV status to at least one friend after a one-year follow-up in
comparison to children who had not disclosed their HIV-positive status. However, research
regarding disclosure and social support have been contradictory and inconsistent, especially in
regards to adherence to antiretroviral medications for HIV. According to the Disclosure
Processes Model, adherence to HIV medications can be facilitated by disclosure in that
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disclosure provides access to social support and allows for individuals to take their medication
publicly, or at the very least in front of their supports to whom they have disclosed. Other
research has shown the opposite, specifically that disclosure has no association with adherence or
may actually lead to nonadherence. People living with HIV/AIDS often experience stigma
surrounding their diagnosis which may lead to psychological distress and chronic anxiety,
ultimately hindering adherence to antiretroviral medications (Guimarães et al., 2008; Sherr et al.,
2008). Waddell & Messeri (2006) found that while social support may in fact predict medication
adherence, social support only seems to matter when individuals have disclosed. Researchers
have had difficulty establishing the connections between social support, disclosure, and
medication adherence due to these inconsistencies but also due to the complex relationships
existing between these mechanisms and the probability that these relationships are mediated by
other psychological factors (Huynh, Kinsler, Cunningham, & Sayles, 2013; Waddell & Messeri,
2006).
In a cross-sectional study conducted in Mexico, 172 participants living with HIV/AIDS
were involved in a study examining antiretroviral adherence behaviors and the relationship to
psychological and social variables (Ybarra Sagarduy, Piña Lopez, González Ramírez, & Fierros
Dávila, 2017). Among these 172 participants, 141 were 100% adherent to their treatment
regimens. The researchers used several measures including the Psychological Variables and
Adherence Behaviors Questionnaire (VPAD-24), the Stress-Related Situations Scale (SVE-12),
the Zung Depression Scale, and the Duke-UNC Functional Social Support Questionnaire, three
of which were adapted and validated in Mexico. Using structural equation modeling, the
researchers found a relationship between personality and medication adherence behaviors.
However, despite low levels of depression and high levels of perceived social support reported
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among participants, no significance was determined in any of the structural models in this study
(Ybarra Sagarduy, Piña Lopez, González Ramírez, & Fierros Dávila, 2017). The positive
behaviors associated with personality, however, were found to have a direct, significant effect on
immune functioning and viral load.
Interpersonal Violence
Interpersonal violence is a broad term which includes child abuse, intimate partner
violence, hate crimes, and sexual assault and rape by a partner or non-partner. Interpersonal
violence has strong implications for health outcomes and health-related behaviors (Blashill et al.,
2011). Interpersonal violence has been associated with increased mental health issues including
PTSD and depression, chronic pain, and increased utilization of healthcare resources. Several
studies have been conducted to explore the links between medication adherence in exposure to
interpersonal violence. In a study conducted by Ramachandran, Yonas, Silvestre, and Burke
(2010), 73% of individuals in a sample of 56 diagnosed with HIV infection reported a history of
interpersonal violence, specifically intimate partner violence. Researchers found higher levels of
medication nonadherence among the 73% with exposure to violence during their lifetime. In
another study conducted in 2010, researchers investigated the impact of intimate partner violence
on adherence to antiretroviral medication. Researchers obtained a sample of 190 participants
who were prescribed a medication regimen for HIV (Lopez, Jones, Villar-Loubet, Arheart, &
Weiss, 2010). It was found that a history of experiencing intimate partner violence was a
significant predictor of medication nonadherence for women but not men. Researchers found a
significant relationship, however, between negative coping strategies and poor adherence
behaviors among men. In a study where researchers tested a path model for nonadherence,
researchers found that interpersonal violence was correlated with poor medication adherence in
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addition to poor quality of life and increased viral load among a sample of 178 HIV-positive men
(Pantalone, Hessler, & Simoni, 2010). Other recent research which has focused on the
occurrence of intimate partner violence experienced by women has suggested that intimate
partner violence and interpersonal violence may lead to higher viral load and increased riskybehavior, including medication nonadherence (Rose, House, Stepleman, 2010; Trimble, Nava, &
McFarlane, 2013). Important to note is that viral load could be an indicator of nonadherence to
medication or even virologic failure.
In a study conducted in Southern California, data was collected from 914 Latina
participants relating to history of abuse (Newcomb, Locke, & Goodyear, 2003). Researchers
explored variables such as family abuse, sexual abuse, and family neglect and their relationship
with outcomes such as HIV-attitudes and HIV-related behaviors. Using structural equation
modeling, the researchers concluded that childhood experiences of abuse do play a role in
predicting HIV-related risk among other negative effects such as psychosocial functioning. A
large study based on the Behavioral Risk Surveillance System Survey (Kessler et al., 2010)
involved assessing for experiences of sexual, psychological, and physical abuse in 48,526 adults
from five U.S. states (Campbell, Walker, Leonard, & Egede, 2016). Multiple logistic regression
models were used to find relationships between experiences of abuse during childhood and
health outcomes. Researchers found that sexual abuse and verbal abuse predicted risky HIV
behavior and depression. This information is important and relevant especially since childhood
abuse and violence are especially prevalent among ethnic minorities, including Latino/as. In
studies conducted among Latino MSM, it has been found consistently that rates of childhood
abuse seem to be higher when compared to non-Latino MSM (Balsam, Lehavot, Beadnell, &
Circo, 2010; Feldman & Meyer, 2007).

104
Impulsivity
Psychiatric disorders and symptoms are more prevalent in people living with HIV/AIDS
and individuals with a diagnosable psychiatric disorder are more likely to be nonadherent to their
medication regimen (Bing et al., 2001; Gonzalez, Batchelder, Psaros, & Safren, 2011),
Additionally, impulsivity and depression have been reported in association with poor adherence
to medication among HIV-positive individuals. In a study conducted with 103 participants, 56%
of whom were diagnosed with mood disorders, researchers found that the participants who
scored high on measures assessing sensation-seeking behaviors and impulsivity were less likely
to adhere to their medication (Liraud & Verdoux, 2001). This effect was found after controlling
for history of substance abuse. In a study conducted in Mexico City among HIV-positive
patients, levels of impulsivity and depression were measured among 1,350 patients, 89% male,
using the State Impulsivity Scale (Iribarren et al., 2011) and the BDI (Beck, Steer, & Brown,
1996). Levels of impulsivity were highest among patients who were depressed, suggesting
greater risk for poor adherence and risky sexual behaviors among depressed patients (VegaRamirez, et al., 2015).
Importance of Current Study
Medication adherence is vital for HIV/AIDS patients. However, research has shown that
adherence continues to be an issue among individuals living with various chronic illnesses. In the
United States, it is estimated that more than 25% of patients with chronic conditions are
nonadherent to their prescribed medication regimens with an annual cost of nonadherence
estimated to be near $290 billion US dollars (Taitel, Jiang, Ewing, & Duncan, 2012). While HIV
medication has improved and become more accessible in many parts of the world, rigorous
adherence to the medication remains an essential part of treatment for improved health outcomes,
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and avoidance of virologic failure and drug resistance. Psychological and social factors have
been well-documented in research as contributing factors to negative health outcomes and poor
adherence to HIV medication in the United States and Mexico. According to the U.S.
Department of Health and Human Services (2016), several factors contributing to nonadherence
are side effects of medication, busy schedule and travel, unstable living conditions, illness or
depression, substance use, fear of disclosing HIV status, or lack of health insurance or finances
to cover the cost of medication. This knowledge supports the need for early intervention
strategies and early screening for risk factors which could contribute to medication
nonadherence. Due to the variability found in the literature regarding adherence, there are
existing implications for repeated studies and testing within new groups of individuals across
cultures and the need for integrative care and collaboration among medical professionals and
mental health professionals. By streamlining care to include better communication and
collaboration among mental health professionals and physicians, there is greater potential for
improved patient outcomes, holistic care, and improved intervention strategies (Winfield,
Sparkman-Key, & Vajda, 2017). A retrospective cohort study conducted in the Midwest of the
United States, evaluated a program which was designed to improve adherence to medication
among new patients receiving statin therapy. The program involved face-to-face counseling
sessions with pharmacists who utilized motivational interviewing techniques to assist patients
with their medication adherence. Adherence was measured using a medication possession ratio
and was based on the benchmark of 80% adherence which is commonly used in medication
adherence research. Researchers found that patients who participated in the counseling program
exhibited greater adherence to their medication regimen than patients who were part of the
comparison group and received usual care. This study not only highlights the effectiveness of
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brief counseling interventions to improve medication adherence but shows the potential for the
involvement of counseling professionals who could participate in the training and coaching of
medical staff in motivational interviewing, empathic responding, and screening for various
psychological risk factors for medication nonadherence.
Research Design
The article will utilize a nonexperimental, cross-sectional research design. This data is
cross-sectional since the data was recorded from a specific group at a single point in time
(Thompson & Panacek, 2007). Cross-sectional research provides a naturalistic view of the
investigated phenomena due to lack of researcher influence which often exists in experimental
research in which variables are intentionally manipulated (Field, 2017). The majority of the data
in this study was self-report collected via intake questionnaire and a battery of self-report
assessments. Clinical mental health and medical professionals provided additional information
on the intake forms in regard to mental health diagnoses, mental health issues identified as
barriers to treatment, and CD4 counts and viral load as determined by laboratory blood tests.
This study investigates psychosocial phenomena that are measurable and objective,
therefore supporting the use of quantitative linear methods to test the research questions
(Bernard, 2013). Previous research on HIV-positive individuals focusing on adherence have used
a variety of research designs and analyses to study factors influencing medication adherence and
nonadherence among people living with HIV/AIDS. Studies reported in the literature utilized
bivariate and multivariate logistic regression models, however, lacked sequential analyses to
control for the influence of pre-existing psychological variables (e.g. Chandwani et al., 2012;
Rotzinger et al., 2016; Weaver, Pane, Wandra, & Windiyaningsih, & Samaan, 2014). Most
recently, in a study conducted in a northern state of Mexico, researchers used structural equation

107
modeling to examine psychological influences on antiretroviral medication adherence in a
population of Mexican people living with HIV/AIDS. This study included variables such as
decision-making, tolerance of ambiguity, tolerance of frustration, motivates to behave,
depression, and social support (Sagarduy et al, 2017). In this model, social support and
depression were found to be nonsignificant in relationship with medication adherence, unlike
other analyses mentioned in the literature where depression and social support were found to be
significant (Grenard et al., 2011; Gonzalez et al., 2009). In the field of HIV/AIDS research,
contradictory literature is the norm, requiring specific models to be tested within new
populations in differing geographic regions, cultures, and ethnic groups. The current data set has
never been analyzed and will contribute to the body of literature on people living with
HIV/AIDS. To better understand the relevance of psychosocial factors in the role of medication
adherence in the population of HIV-positive individuals in Mexico City, a regression analysis
was most helpful since regression analyses assist in studying the relationships between several
predictor variables and an explicit outcome (Heppner, Wampold, & Kivlighan, 2008). For this
study, a sequential logistic regression analysis was utilized in which the researcher specified the
order of entry of the predictor variables based on a theoretical rationale (Petrocelli, 2003;
Tabachnick & Fidell, 2014). Since contradictory findings present themselves in the literature, a
sequential logistic regression controlled for pre-existing psychosocial variables (e.g. depression
and major stressors experienced within the past year) based on the theoretical framework
presented in Chapter Two to provide knowledge of the extent to which disclosure, exposure to
violence, social support, and impulsivity impact medication adherence in this population. The
researcher entered the pre-existing psychosocial variables first to control for the effects of these
variables to understand the effects of disclosure, social support, impulsivity and violence beyond
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that accounted for by depression and other major stressors. This allowed the researcher to
perform a more rigorous analysis of the relationship between the variables of interest and
medication adherence.
Included in the model for the current study are 6 predictor variables: disclosure
(categorical), social support (continuous), exposure to violence (continuous), stressors
(continuous), impulsivity (continuous), and depression (continuous). The outcome variable is a
binary categorical variable, medication adherence to antiretroviral medication for HIV treatment.
All participants in the sample have been diagnosed with depression by a clinician but may have
varying BDI scores. Additionally, patients recorded the number of major stressors experienced
within the past year. As such, depression scores and stressors will be included within the first
block of the sequential regression model to control for the effects of these variables. Disclosure,
social support, exposure to violence, and impulsivity will be included in the second block of the
sequential regression model. This model was utilized to analyze two subsets of the data which
were subsequently created after the initial data screening in order to account for uneven groups
in the dependent variable. Additionally, bivariate correlations were conducted to determine
relationships between CD4 counts, social support, and exposure to violence and a one-way
ANOVA was conducted to determine if significant mean differences existed between disclosure
groups.
Data Collection
Data was collected by mental health clinicians from 2010-2016 at a large specialized
clinic in Mexico City. In this clinic, mental health clinicians work and function as part of a
separate mental health department with their own set of protocol and work flow procedures.
Most typically, patients arrive to the clinic to receive free HIV testing from the medical team.
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Once a patient has been diagnosed with HIV, the patient is sent for laboratory blood tests to
obtain viral load and CD4 counts. The patient is also referred to the mental health program for a
psychological evaluation, a brief intervention, and a treatment plan. The psychological
evaluation consists of a comprehensive intake form and a battery of 6 assessments. The intake
form and 2 of the 6 assessments are part of the current study and will be explained in more detail
in the section regarding instrumentation. Other patients referred to the mental health program for
evaluation are transgender-identified individuals who are both HIV-positive and HIV-negative,
and HIV-positive individuals who have been diagnosed elsewhere prior to presenting to the
specialized clinic. In the current data set, the researcher used a subset of individuals all
diagnosed with HIV.
Participants
Sampling Criteria. The researcher used a convenience sample of individuals from the
full data set based on specific criteria. Convenience sampling in health research is advantageous
as it helps the researcher to gather useful information from a specific set of participants
accessible to the researcher which may have not been possible using other sampling techniques,
such as probability sampling (Tyrer & Heyman, 2016). Additionally, the purpose of this study
was not generalizability, but investigation of a specific population in a particular geographic
region, of which this sample is representative. Inclusion criteria for this study was a diagnosis of
HIV or AIDS, current prescribed antiretroviral medication regimen, sexually transmitted HIV,
and a clinician diagnosis of depression. This resulted in a total of 601 participants to be included
from the original data set which included data of 4,842 patients. In the data set containing 601
participants, the two groups of the dependent variable were uneven so two random samples were
taken from the larger group (“adherent”) and assigned to two smaller subsets including the full
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nonadherent group to create two subsets of 146. This number was determined through a power
analysis discussed in the next section.
Power Analysis. Power represents the ability to correctly reject a null hypothesis. It is a
function of the magnitude of the effect, the probability level chosen for statistical significance,
and the sample size used in the study (Keith, 2015). The researcher used G*Power 3.1 to
determine the minimum sample size necessary to yield significant results in a sequential logistic
regression analysis. For an analysis with a medium effect size (f2) of .15, error probability (α) of
.05, power (β) of .95, and six predictor variables, the power analysis indicated an optimal sample
size of 146. According to Cohen (1988, 1992), researchers should achieve a minimum power of
.80. The statistical power of the current study indicates that there is a 95% chance of detecting an
effect if it exists.
Participant Demographics. All participants were patients at a specialized clinic in the
center of Mexico City residing in one of Mexico City’s 16 boroughs or in close proximity to the
city limits. Of the 146 participants included in Data Set 1 of this study, 122 identified as male, 20
identified as female, and 2 identified as transgender female. Age ranged from 17-67. For marital
status, 110 participants were single, 33 were married or partnered, and 3 were widowed.
Regarding occupation, 44 of the participants were unemployed at the time of their intake. In
terms of religion, 72 of participants identified as Catholic. Regarding sexual orientation, 101 of
participants identified as homosexual, 12 as bisexual, and 30 as heterosexual. Lastly, 98 of
participants had a detectable viral load at the time of their intake and 44 had an undetectable viral
load.
Of the 146 participants included in Data Set 1 of this study, 130 identified as male, 15
identified as female, and 1 identified as transgender female. Age ranged from 17-64. For marital
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status, 115 participants were single, 29 were married or partnered, and 2 were widowed.
Regarding occupation, 38 of the participants were unemployed at the time of their intake. In
terms of religion, 72 of participants identified as Catholic. Regarding sexual orientation, 104 of
participants identified as homosexual, 16 as bisexual, and 26 as heterosexual. Lastly, 93 of
participants had a detectable viral load at the time of their intake and 50 had an undetectable viral
load.
Recoding
Violence, stressors, and disclosure responses were gathered via intake questionnaire
checklists. For example, participants were asked whether they had experience psychological,
emotional, physical, or economic abuse during the course of their lifetime. This variable was
recoded as an ordinal variable ranging from 0-4 where 0 indicated no exposure to violence, and 4
indicated exposure to each of the types of violence listed in the questionnaire. Stressors
experienced during the past year was included as a checklist of 7 different stressors on the intake
evaluation which was coded as an ordinal variable in the data set where 0 indicated no exposure
to major stressors and 7 indicated exposure to all stressors listed in the questionnaire. Two
variables in the data set corresponded to disclosure to family of HIV or AIDS status. These
variables were transformed to create a new variable which was coded as 0 for no disclosure to
family of HIV status, 1 for disclosure to family with reaction of support, 2 for disclosure to
family with reaction of rejection, and 3 for disclosure to family with reaction of indifference.
BDI and EIE scores were aggregated to form sum variables for each of the scales. BDI, EIE, and
social support variables did not need further coding or transformation as they are continuous
scale variables.
Data Analysis
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For the first research question, a correlational analysis was conducted in order to examine
the relationships between the continuous variables social support, violence, and CD4 counts.
Next, an ANOVA was conducted to estimate the mean differences in CD4 counts among
disclosure groups. Prior to running correlational analyses, data was screened to determine if a
linear relationship existed between the variables. Data was also screened for normality. The
researcher used SPSS to construct scatterplots and boxplots and to compute normality tests. The
violence, social support, and CD4 variables were determined not to be normally distributed
according to the Shapiro-Wilk’s test (p < .05). Due to non-normality of the data and
monotonicity as observed in the produced scatterplots, a Spearman correlation was conducted on
the three variables.
Using SPSS, Spearman correlations were utilized to determine if a relationship existed
among violence, social support, and CD4 counts. Specifically, the researcher aimed to identify
relationships between violence and CD4 counts and social support and CD4 counts. In Data Set
1, the analysis showed a significant small positive correlation between violence and CD4 counts
(rs = .189, p < .05). In Data Set 2, neither violence nor social support were found to have
statistically significant relationships with CD4 counts.
Table 1. Correlation Coefficients (Spearman Correlation) of Violence, Social Support, and
CD4 Variables for Data Set 1.
Violence
Social Support
CD4
Violence

-

Social Support

-.212*

-

CD4

.189*

.055

-

Table 2. Correlation Coefficients (Spearman Correlation) of Violence, Social Support, and
CD4 Variables for Data Set 2.
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Violence
Violence
Social Support
CD4

Social Support

CD4

-.272*

-

.112

.036

-

Prior to running the ANOVA to determine mean differences across disclosure groups,
assumptions were checked. Assumptions of a one-way ANOVA are a continuous dependent
variable, a categorical independent variable with two or more independent groups, independence
of observations, no significant outliers in the groups of the independent variable in terms of the
dependent variable, a normally distributed dependent variable for each group of the independent
variable, and a dependent variable with a normal distribution. SPSS was utilized to construct
boxplots for each disclosure group and determined that there were no significant outliers among
each of the groups. A Shapiro-Wilk’s test determined that two groups (No Disclosure and
Acceptance from Family) were not normally distributed (p < .05) and the groups corresponding
to individuals who were rejected by family and whose families were indifferent to their
disclosure were approximately normally distributed (p > .05). A one-way ANOVA was
conducted to determine estimates of mean differences between disclosure groups on their CD4
counts. The analysis determined that there were no statistically significant mean differences in
CD4 counts between the groups.
Research Question Two: To what extent do disclosure, social support, impulsivity, and
exposure to violence predict medication adherence in HIV-positive individuals after
controlling for depression and major stressors experienced within the past year?
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For research question two, a logistic regression model was utilized to estimate the
contribution of each predictor variable while simultaneously taking other predictor variables into
account and was tested across two groups, each composed of the smaller nonadherent group and
a random sample of the adherent group due to the unbalanced levels in the outcome variable.
This strategy was utilized in order to assess the generalizability of the model (Chan, 2004; Katz,
1999). The analyses were conducted in two steps into which BDI scores and stressors were
entered first followed by psychosocial variables of interest to identify the influence of depression
and stress before taking other possible risk factors for medication nonadherence into account.
The researcher conducted two two-step binary logistic regression analyses to determine if
the addition of disclosure of HIV status to family members, exposure to violence, social support,
and impulsivity improved the prediction of medication adherence over depression and stressors
experienced over the past year. The dependent variable for the analyses was medication
adherence, self-reported during an intake questionnaire. Stressors experienced in the past year
and depression scores as measured by the BDI were entered into the first block of the model as
control variables. Disclosure of HIV status to family members, impulsivity as measured by the
EIE, exposure to violence, and social support were entered into the second step of the model. See
Table for details on the full regression model. With regard to the full model, variables that were
statistically significant for both Data Set 1 and Data Set 2 are considered to robustly predict the
medication adherence outcomes (Cohen, Cohen, West, & Aiken, 2003).
Logistic regression analyses were computed separately for each random sample of the
adherent group that was taken and will be referred to Data Set 1 and Data Set 2, respectively.
The omnibus test for Step 1 of the analyses yielded a nonsignificant Hosmer and Lemeshow test
for Data Set 1 ꭓ2(8) = 11.775, p > .05, and Data Set 2 ꭓ2(8) = 5.098, p > .05. This indicates that
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the overall model fit of the psychosocial predictor variables was statistically reliable in
predicting medication adherence at the time of intake. The Negelkerke R2 for Step 1 variables
was .154 for Data Set 1 and for Data Set 2 was .120, indicating small effect sizes for the
associations between the selected psychosocial variables and medication adherence. In these
analyses, depression as measured by the BDI scores was a significant predictor of medication
adherence in both groups. The value of Exp(B) indicated that the odds of nonadherence to HIV
medication increased 8.9% for every 1 point increase in BDI scores in Data Set 1 [Exp(B) =
1.089, 95% CI =1.040-1.140] and by 8.6% in Data Set 2 [Exp(B) = 1.086, 95% CI = 1.0361.140].
In Step 2, selected psychosocial variables were entered into the regression analyses for
the two groups. The results of the Hosmer and Lemeshow test indicated that the overall model fit
of the six variables was statistically reliable in distinguishing between adherence or
nonadherence to ART at the time of intake evaluation in both Data Set 1 ꭓ2(8) = 6.345, p = .609,
and Data Set 2 ꭓ2(8) = 13.870, p = .085. The Nagelkerke R2 for Data Set 1 was .240 and for
Data Set 2 was .197, indicating that the full model explained 24% and 19% of the variation in the
outcome variable of Data Set 1 and Data Set 2, respectively. The inclusion of the psychosocial
variables in Step 2 resulted in an increase of 4.8% and 2.8%, respectively, in variance accounted
in the prediction of medication adherence beyond the variance accounted by Step 1 variables
only. The overall accuracy of the model to predict participants to be nonadherent at the time of
intake evaluation was 69.2% in Data Set 1 and 65.8% in Data Set 2. In Data Set 1, the model
correctly classified 82.1% of participants who were adherent and 54.4% of participants who were
nonadherent. In Data Set 2, the model correctly classified 74.4% of participants who were
adherent and 55.9% of participants who were nonadherent. In these analyses, none of the

116
psychosocial factor variables were found to be a significant predictor of medication adherence in
both groups. However, impulsivity scores as measured by the EIE were found to be significantly
and positively related to medication nonadherence in Data Set 1 and exposure to violence was
found to be significantly and positively related to medication nonadherence in Data Set 2. For
complete statistics of binary logistic regression analyses for both groups, see Table 11 and 12.
Table 11. Binary Logistic Regression Coefficients of Data Set 1.
B

SE

Wald

df

Sig.

Exp(B)

Stressors

.071

.189

.142

1

.706

1.074

BDI

.038

.031

1.536

1

.215

1.039

EIE

.052

.026

3.973

1

.046

1.053

4.700

3

.195

Disclosure
No Disclosure
(Reference)

Support

.056

.462

.015

1

.904

1.058

-1.105

.795

1.930

1

.165

.331

.681

.588

1.341

1

.247

1.975

Violence

.266

.175

2.305

1

.129

1.305

Social Support

-.041

.062

.439

1

.508

.960

Constant

-1.316

.485

7.348

1

.007

.268

Rejection
Indifference

Table 12. Binary Logistic Regression Coefficients of Data Set 2.

Stressors

B

SE

Wald

df

Sig.

Exp(B)

.011

.156

.005

1

.946

1.011
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BDI

.035

.035

1.004

1

.316

1.036

EIE

.044

.028

2.416

1

.120

1.045

3.321

3

.345

Disclosure
No Disclosure
(Reference)

Support

.681

.455

2.237

1

.135

1.975

Rejection

-.469

.864

.294

1

.588

.626

Indifference

.323

.517

.390

1

.532

1.381

Violence

.358

.176

4.118

1

.042

1.431

Social Support

.001

.063

.000

1

.985

1.001

-1.768

.518

11.653

1

.001

.171

Constant

Discussion
The aim of this study was to investigate the relationship between impulsivity, social
support, disclosure of HIV-positive status to family members, exposure to violence and
medication adherence. The purpose of this study was to add to the existing body of literature
regarding medication adherence among HIV-positive patients while highlighting psychosocial
factors which have the potential to impact adherence behaviors. Further, this study controlled for
depression and life stressors which have found to be predictive of adherence behaviors and poor
health behaviors in previous studies. The researcher hopes to support the mission of the Clínica
Especializada Condesa to establish streamlined care and best practices for the treatment of their
patients and to also support the need for counselor interventions in mental health programs
targeting the treatment of HIV-positive individuals.
The researcher conducted this study using an archival data set comprised of data
collected by researchers and medical staff at the Clínica Especializada Condesa of Mexico City.
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The final data set used for this dissertation included 601 participants from which two subsets
were created, each containing 146 participants. Ages of participants ranged from 17-67 years.
Participants completed intake questionnaires including questions regarding experiences of
violence throughout the lifetime, disclosure of HIV status to family members, social support, life
stressors experienced over the past year, and various other demographics including age, sexual
orientation, gender, borough of residence, employment status, and household information.
Participants also completed assessments regarding impulsivity, depression, substance use, and
physical and mental health functioning. Medical professionals recorded information derived
from laboratory blood samples such as CD4 counts and viral loads. Mental health professionals
recorded mental health diagnoses based on their clinical judgement using the DSM. The
researcher conducted bivariate correlations, a one-way ANOVA, and two hierarchical logistic
regressions to address the research questions.
Major Findings
The results of this study contribute to the extensive body of literature already in existence
in the field of HIV and AIDS medication adherence research. The findings include varying levels
of support for the research questions and hypotheses.
Research Question One
Bivariate correlations were conducted to investigate the relationships between CD4 cell
counts and social support and exposure to violence. Results varied in the relationships between
Data Set 1 and Data Set 2. In Data Set 1, the correlations showed a significant positive
correlation between violence and CD4 counts, indicating that as violence increased, CD4 counts
increased. The relationship between social support and CD4 was not statistically significant. In
Data Set 2, the analysis resulted in no statistically significant correlations between neither social
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support and CD4 nor violence and CD4. Therefore, researchers failed to reject the null
hypotheses for this analysis. The hypotheses predicted a positive relationship between CD4
counts and social support and negative relationship between CD4 counts and exposure to
violence.
A one-way ANOVA was conducted to examine the differences in CD4 counts between
disclosure groups (no disclosure, family accepted, family rejected, family indifferent). In both
Data Set 1 and Data Set 2, there were no significant differences between the four disclosure
groups indicating a failure to reject the null hypothesis.
Research Question Two
A sequential logistic regression was conducted to examine the relationship between
exposure to violence, impulsivity, social support, disclosure to family and medication adherence
when controlling for depression scores and stressors experienced within the past year. In support
of the research question, the model tested in both Groups One and Two were found to be
significant overall. While there were no factors which were found to be significant predictors of
medication adherence in both groups, impulsivity was found to be a significant predictor of
medication nonadherence in Data Set 1 and exposure to violence was found to be a significant
predictor of medication nonadherence in Data Set 2. Because neither variable was found to
robustly predict medication adherence (resulting in significance in both data sets), the researcher
failed to reject the null hypothesis for this research question. While the model controlled for
stressors and depression, stressors were not found to a be a significant predictor of medication
nonadherence in either group while depression was statistically significant in each group. While
neither impulsivity nor exposure to violence were significant across both groups, this
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information is noteworthy in the consideration of this population and in their treatment as
medication adherence has significant implications for HIV-positive patients.
Supportive Findings
This research suggests that both increased exposure to violence and higher scores on a
scale measuring impulsivity are predictive of increased probability of nonadherence to ART.
Medication adherence is vital for improving health outcomes with physicians emphasizing 8095% adherence for optimal health outcomes. However, physicians treating and researching HIV,
specifically, suggest 95-100% adherence to ART in order to prevent replication of HIV in the
bloodstream, to strengthen the functioning of the immune system, to lower the likelihood of
transmission, and to decrease the odds of developing drug resistant strains (National Institutes of
Health, 2017a; Osterberg & Blaschke, 2005; Smith et al., 2003).
Previous research has supported the association between violence and nonadherence to
medication among HIV-positive individuals. While the probability of medication nonadherence
significantly increased in only one of the subsets in this study, interpersonal violence has been
associated with increased mental health issues including PTSD and depression and has also been
associated with medication nonadherence in several studies found in the literature (Blashill et al.,
2011). The current study included participants who had experienced physical, psychological, and
emotional abuse. This is consistent with studies that have found higher levels of nonadherence to
ART among individuals who have experienced intimate partner violence, interpersonal violence,
sexual abuse, and verbal abuse (Campbell et al., 2016; Lopez et al, 2010; Pantalone et al., 2010;
Ramachandran et al., 2010). Important to mention is also the relationship between ethnic groups
and experiences of violence throughout the lifetime. While the sample in the study was an
international sample comprised entirely of Mexican nationals, in the United States it has been
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found that rates of childhood abuse seem to be higher in Latino MSM when compared to nonLatino MSM. This information is relevant especially since child abuse and violence are prevalent
among ethnic minorities, including Latino/as (Balsam et al., 2010; Feldman & Meyer, 2017).
This finding is important since research supports a connection between early childhood traumas
and risky-behaviors later in life.
Contradictory Findings
As was found during a review of the literature documented in Chapter Two of this
dissertation, literature regarding the study of medication adherence in HIV-positive populations
contains contradictory findings. This study did not find any significant results in the relationships
between medication adherence, social support, and disclosure of HIV status to family members.
Although there were no significant findings in this study, it is important to not dismiss these
factors. Non-significant findings could be due to the limitations discussed later in this section or
due to nuances of the specific population targeted for this investigation.
Social support has long been explored as a component in health outcomes for individuals
with chronic illness. For individuals with HIV and AIDS, social support and disclosure to family
and loved ones may be complexly interrelated. Individuals may disclose their HIV-positive
status to strengthen their relationships and to gain support from others but may also avoid doing
so due to fear of conflict and rejection (Chaudoir et al., 2011). Several studies have shown the
connection between disclosure of HIV status, decreased symptoms of depression, and improved
immune functioning (Hays et al., 1993; Sherman et al., 2000; Strachan et al., 2007). Yet
disclosure of HIV-positive status may increase stigma which has been related to psychological
distress and chronic anxiety, ultimately presenting a hinderance for medication adherence
(Guimarães et al., 2008; Sherr et al., 2008). In yet another study, researchers found that social
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support may in fact predict medication adherence but only when individuals have disclosed their
status to others (Waddell & Messeri, 2006). It is evident that researchers have found difficulties
establishing consistent connections between these constructs among HIV-positive populations as
the researcher has encountered in the current investigation.
Implications
The association between exposure to violence, impulsivity, and medication nonadherence
has important implications for conceptualizing and administering treatment to individuals with
HIV and AIDS. Furthermore, taking into consideration previous research and the factors
examined in the current study, there are implications which must be considered for HIV and
AIDS treatment, counselors working in healthcare settings, and for teaching and counselor
education programs as our healthcare and treatment delivery system continue to move toward an
environment that embraces streamlined interprofessional collaboration and integrative care.
Implications for HIV and AIDS Treatment
In their 2017 report on HIV drug resistance, the World Health Organization discusses the
global target 90-90-90 which have been widely adopted. This target reflects the efforts of the
global community to achieve the diagnosis of 90% of all people with HIV infections, providing
treatment to 90% of the individuals who have been diagnosed, and guaranteeing that 90% of
those receiving treatment reach virologic suppression by the year 2020. As of the end of 2016,
those numbers were 70%, 77%, and 82%, respectively (World Health Organization, 2017). The
World Health Organization has emphasized the importance of addressing HIV drug resistance
and has guided 26 countries in implementing HIV drug resistance surveillance surveys. One of
these countries is Mexico which has seen more than 10% pretreatment non-nucleoside reversetranscriptase inhibitor (NNRTI) resistance in three of six surveys (World Health Organization,
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2017). NNRTIs are considered first line of treatment of individuals with HIV, as such, drug
resistance to these medications may come with a great cost including difficulty achieving viral
suppression, increased chances of virologic failure or death, increased likelihood of
discontinuing treatment, and increased probability of developing new HIV drug resistant
mutations (World Health Organization, 2017). Suboptimal adherence to medication can increase
the likelihood of developing drug resistant strains and virologic failure, also increasing the
chances of transmitting a drug resistant strain to others (World Health Organization, 2017).
Medication adherence in HIV and AIDS treatment is an urgent public health matter and must be
addressed in clinics and treatment facilities worldwide.
Studies have focused on the causes of virologic failure and drug resistance from a
medical standpoint but have also begun to increasingly identify psychological, social, and
economic factors which influence adherence behaviors. Studies have been conducted in countries
across the globe to help better understand these psychosocial factors influencing adherence and
have identified similar trends among low- and middle- income countries. Substance use, cost of
travel and access to transportation, adverse side-effects, lack of reminder tools, and perceived
social acceptance have all been identified as factors influencing adherence (Shigdel, Klouman,
Bhandari, & Ahmed, 2014). In addition to these aforementioned factors, others may include cost
of medications, age, sex and gender, education, occupation, household composition, physical
disabilities, self-esteem and motivation, mental health conditions, social status and social
support, homelessness, incarceration, and cultural models of health and disease (Castro, 2005).
The clinic in Mexico has been at the forefront of treatment in the country and has
included many items on their intake questionnaires addressing factors and behaviors such as
those mentioned above: social support, mental health conditions, social support, living situation
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and household composition, and occupation. The results of this study support the continued
screening for factors associated with medication adherence and nonadherence in order to best
understand the trends in specific populations as well as to best predict who will be more likely to
not adhere for early interventions to take place. This will help to guide the fine-tuning of intake
processes, evaluations, and assessments used to garner information from clients. This also
supports the need for streamlined care with professionals from various backgrounds working
collaboratively in order to create approaches that are holistic in nature and address the wholeness
of an individual and their systems.
Implications for Counselors in Health Care Settings
Nonadherence to medications is associated with costs of over 1 billion dollars in the
United States yearly with estimates of 33-69% of hospital stays attributed to poor adherence to
medications (Palacio, Garay, Langer, Taylor, Wood, & Tamariz, 2016). This overwhelming
statistic indicates a major problem in public health and signal a need for improved quality of care
and intervention. Recently, there has been a trend toward integrating services in the delivery of
healthcare. Integrative care has been increasingly recognized as essential to improving the
quality of care to individuals seeking treatment (Shallcross, 2013). When considering the
treatment of HIV and AIDS patients, counselors could play a crucial role in delivering treatment
which is holistic and is targeted toward achieving best outcomes. Many of the factors influencing
adherence to HIV medication are issues which counselors are trained to handle throughout their
education. HIV and AIDS impacts many systems in the individual’s life including social,
psychological, and biological aspects. Counselors today are dealing with some of the most
complex issues which face our society, making counselors prepared to deal with the array of
complexities which HIV and AIDS patients face from the time of diagnosis (Quealy-Berge &
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Caldwell, 2004). Counselors are well-versed in communication skills which are essential to the
practice of healthcare in order to convey compassion and provide care in an ethical manner
which focuses on the client-provider relationship. Research has shown that effective
communication with emphasis on compassion and ethical practice leads to improved health
outcomes, better quality of care, and increased patient and clinician satisfaction (Rider at al.,
2014). This supports the need for counselors in integrated care since counselors are trained to
form supportive and affirmative working alliances with their clients and are trained to provide
empathic responses, show compassion, and be aware of biological, psychological, and social
domains of a client’s experiences (Bowen & Moore, 2014). The International Charter for Human
Values in Healthcare have identified fundamental values essential to best practices including
empathy, genuineness, acceptance, self-awareness, multicultural competence, attention to
wellness, which are qualities identified as important characteristics for workers in the human
services (International Charter for Human Values in Healthcare, 2011; Neukrug, 2017).
While counseling is a normal part of HIV testing, brief counseling interventions
throughout the course of treatment are not currently a standard of treatment especially not with a
focus on medication adherence. Several studies have been documented which provide
information on the impact of counseling interventions on medication adherence in HIV-positive
samples. One study piloted an adherence program consisting of one-on-one counseling which
targeted patients starting ART for the first time. These patients were to attend two counseling
sessions before initiating their ART regimen which focused on education on HIV and AIDS,
resistance, and therapeutic failure, evaluation of family support, and identification of the barriers
and strategies related to adherence (Winter, Halpern, Brozovich, & Neu, 2014). Researchers
discovered that individuals who received the counseling intervention had improved rates of
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adherence when compared to those who did not receive the counseling intervention. Adherence
in this study was measured by appointment attendance; however, attendance was associated with
an increase in CD4 counts which is often an indicator of adherence to ART. Another study
examined brief medication adherence strategies implemented by pharmacists which emphasized
the need for personalized adherence strategies based on the specific patient’s lifestyle and the
need for providing follow-up care for individuals who have been identified as nonadherent to
their medications (Mangan, Fowers, & Lengel, 2012). Yet another study examined the
effectiveness of motivational interviewing techniques on an HIV-positive sample in terms of
adherence to ART. Motivational interviewing, a skill taught in most counseling programs, is an
approach which utilizes cognitive behavioral techniques aiming to help individuals express and
work through their ambivalence to address specific behaviors while encouraging clients to selfauthorize and create solutions to their problems (Miller & Rollnick, 2012; Palacio et al., 2016).
Researchers found that motivational interviewing interventions improved medication adherence
although simultaneously acknowledged that improving adherence is difficult due to the
complexity of its determinants and the inconsistent definitions of adherence existing in the
literature. While research has supported the effectiveness of motivational interviewing in primary
care and community clinics in the United States, there are inconsistent training methods and
modes of delivery documented as well as duration of time exposed to motivational interviewing
interventions and outcome measures (Palacio et al., 2016). This supports the need for further
research in this area, establishment of best practices in terms of training and utilization of
intervention programs targeting medication adherence so there is a standard of measurement
across healthcare settings. Additionally, since counselors are skilled in motivational interviewing
and are trained to work with client ambivalence, it could be a seamless opportunity for
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counselors to play an integral role in achieving the target for optimal medication adherence
among HIV and AIDS patients. This could involve counselors providing coaching and training to
physicians and other medical staff or to be the leaders in developing and implementing
counseling interventions with these aims in mind.
While counselors in healthcare are valuable assets to the treatment team, counselors may
face certain challenges related specifically to their interactions with professionals from other
disciplines. Interprofessional collaboration may present its challenges in healthcare settings yet
remains a vital function especially in the treatment of HIV and AIDS which can be complex and
involve many aspects of identity and impact the interlocking systems in which an individual’s
problems exist.
In the clinic in Mexico, there are several departments with a variety of healthcare
professionals attempting to work together to facilitate streamlined holistic care of HIV and AIDS
patients. Mental health professionals are part of this team. While the counselor identity is not yet
well-established in Mexico as it is in the United States, the counseling profession continues to
struggle in the United States to establish a professional identity which is cohesive (Mellin, Hunt,
& Nichols, 2010). This lack of shared identity may exacerbate the challenges faced by
counselors when faced with interprofessional collaboration since there are many overlapping
characteristics with other helping professions. Despite these challenges, interprofessional work is
increasingly supported as an optimal approach to healthcare service delivery requiring the
expertise of professionals from multiple disciplines to address complex issues. Scholars
including McAuliffe and Eriksen (1999) argue that counseling can be readily differentiated from
other helping professions by its emphasis on development, prevention, and wellness, all
necessary components of treatment in interprofessional settings.
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When considering the role of counselors working with HIV and AIDS patients, there is a
complex interplay of systems which are impacted in the individual’s life guided by their
diagnoses, symptoms, medication regimen, psychological processes, and resulting in issues with
relationships, occupation, finances, etc. While counseling has traditionally been seen as a
profession which focuses on the individual, this implicates the need for greater emphasis on
systems theory in counseling programs and increased focus on ecological and contextual models
highlighting the interplay of sociocultural forces (Arredondo, Shealy, Neale, & Winfrey, 2004).
In interprofessional healthcare environments, counselors must adapt to dynamics of the
workplace and the language and pace of physicians while also remaining confident in their
knowledge and craft.
Implications for Counselor Education
Counselor education programs could benefit from implementing more coursework
focused on integrative care which aims to increase knowledge of medications not only for
psychiatric issues but also for HIV and other common ailments (Arredondo et al., 2004). Mellin
et al. (2010) also suggest increased focus on positive psychology, solution-focused approaches,
cognitive behavioral therapy, brief therapy, stress management, relaxation techniques, family
systems work, motivational interviewing, strength-based approaches, and wellness-based
approaches. In considering the immense impact of HIV and AIDS on the individual and the
individual’s systems and relationships, these aforementioned approaches would be optimal in the
development of strategies targeting adherence counseling programs as well as in facilitating
interprofessional collaboration. Offering students opportunities to hone these skills during their
programs using hands-on experiences through mock simulations, practicums and internships, and
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scholarship opportunities is not only ideal but vital as our society shifts toward new models of
care.
Teaching. As treatment models continue to shift toward more holistic, integrative, and
interprofessional approaches, counseling students would benefit from further training in
ecological and systems theories in order to create a stronger thread throughout counseling
programs which emphasizes collaborative efforts needed to achieve optimal service delivery.
Since counselors are increasingly entering positions requiring them to work in healthcare settings
and dealing with issues relating to chronic illnesses including HIV and AIDS, counselor
educators might consider the development of specialized tracks within their counseling programs
which not only emphasize systemic models but provide coursework aimed to prepare students
for addressing health concerns, the mind-body connection, holistic and alternative forms of
medical treatment, and integrative care. This may require a shift in the traditional views of
counseling and counselor education.
Millen, Hunt, & Nichols (2011) conducted a qualitative study on counselor professional
identity which revealed several stereotypes that exist within the counseling field regarding
distinctions between the helping professions of social work, psychology, and counseling. The
findings indicated that several of the participants believed that counseling was more focused on
the individual at a microlevel, on wellness, and on personal growth rather than systemic issues,
global issues of functioning, testing and assessment, and case management which were seen as
more characteristic of social work and psychology. These views are problematic as counseling
does require a systemic focus for many of the complex sociocultural issues clients will present
during a session. Considering a complex issue such as HIV and AIDS, counselor educators have
the responsibility for underlining the value of systems thinking and how these approaches can be
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used to conceptualize work with individuals living with HIV and AIDS and other chronic
illnesses including the manner in which the illnesses impact clients’ worldviews and contextual
experiences within various interlocking systems in their lives. Counselor educators have the
responsibility to impart with counseling trainees the importance of counseling work in health
care settings and to stress that counselors do belong alongside doctors, nurses, and social
workers, for example. To effectively address integrative care models, counselor educators should
include specific topics in their coursework and lesson plans including but not limited to the
context of integrative mental health care, evaluating a client from an integrative perspective,
recommending treatment and making referrals, and clinical problem solving (Lake, 2009).
Having more practice with these concepts throughout the course of their education will better
prepare students to understand the complexities of issues such as medication adherence and the
importance of a systemic approach to dealing with the issue. Counselor educators can achieve
this through the use of case vignettes, guest lecturers, and including options for integrative care
practicum and internship experiences.
Supervision. A predominant developmental model often used in clinical supervision is
the Integrated Developmental Model (IDM) (Stoltenberg, McNeill, & Delworth, 1998). This
model is based on the notion that supervisees go through phases, or levels, of development in
their work. In each of these levels, the focus is on the motivation of the supervisee, the autonomy
of the supervisee, and the awareness of the supervisee. Supervisors can use this practical model
to assess the developmental level of the supervisee in order to accurately support, challenge, and
promote growth with appropriate supervision interventions and strategies. A clear strength of
this model is that it focuses on the developmental level of the supervisee. This helps the
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supervisor to conceptualize the supervision process and relationship as well as to be sure to use
the most appropriate techniques to facilitate professional growth and client welfare.
Using the IDM to conceptualize work with a supervisee who has clients living with HIV
and AIDS is helpful in creating a framework for training counselors in integrative care settings.
As counseling trainees embark on their practicum experience, it is essential for supervisors to
share knowledge regarding systemic approaches to illness and coping and to work with the
supervisee to encourage the understanding of how a diagnosis of HIV or AIDS can impact not
only a person’s health but also their worldview, social interactions, overall psychological
wellbeing, and health behaviors such as medication adherence. Supervisees early on in their
clinical experiences tend to be limited in their self-awareness and are unsure of their abilities in
the therapeutic relationship. Supervisors can encourage supervisees to develop their sense of
self-efficacy by arming the supervisee with information preparing them to assess for global
issues of functioning and risk factors such as substance use which could be indicators of risky
health behaviors, including nonadherence to medication.
As supervisees continue to gain confidence in their abilities, clinical work will continue
to become more challenging as they gain new responsibilities. Supervisors should encourage
supervisees to become more autonomous and assist them as they experience internal conflicts or
resistance. These factors may be especially important for counselors working in interprofessional
healthcare settings where they may experience difficulties working with professionals from other
backgrounds such as medicine and social work. Supervisors are an integral part of a trainee’s
development and can support supervisees while challenging them for their growth. As trainees
work with populations such as HIV-positive individuals who will challenge their knowledge of
interlocking systems, supervisors have the responsibility to coach and educate yet also ensure
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proper multicultural competencies and skills relating to evaluation and assessment regarding risk
factors and monitoring of health behaviors impacting overall functioning.
Limitations
There are several limitations to this study which should be given consideration when
interpreting the results of the current investigation. First, there are methodological concerns.
Using logistic regression limits the outcome to using a categorical variable. Additionally, logistic
regression tends to be vulnerable to overconfidence so the model could appear to have more
predictive power than it actually does. The sample size utilized for the study was small for a
logistic regression analysis. The sample size used was the minimum sample size needed to
achieve power according to an a priori G*Power analysis. Furthermore, the sample was reduced
significantly from its original size. The original data set included data from approximately 4,800
patients of the clinic which was reduced to a sample of 601 participants. This occurred due to the
sampling process which was based on inclusion criteria. This was also due to excluding
participants based on the assessments included as part of the intake evaluation at the clinic which
had missing information that could not be imputed. After reducing the data set to 601, the
distribution of cases among the two groups of the dependent variable medication adherence was
significantly skewed. In order to account for this skewness, the researcher obtained two random
samples from the adherent group which was larger and merged each of these samples with the
nonadherent participants to form two separate subsets or samples. This strategy was used in
attempts to best maintain the integrity of the sample, however, considering all aforementioned
limitations, it is certainly a concern in that it may not capture the true essence of the population.
A similar issue exists within the distribution of cases among the categorical independent variable
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representing disclosure to family members of HIV-status. Cases were not evenly distributed
among the four groups which may also present a limitation for the current analysis.
Regarding the independent variable representing exposure to violence, during the intake
process, participants reported their experiences of abuse according to four different categories
throughout the lifetime. This information was transformed into an ordinal variable which
indicated how many types of these categories had been experienced throughout the lifetime
instead of which specific types. This may be considered a limitation since there may be clear
differences between groups in terms of their adherence behaviors. Additionally, information that
was collected during the intake process regarding these experiences was intentionally excluded
from the model but could have been relevant. This information pertained to stages of life during
which the types of abuse or violence were experienced and could have added a richness to the
study: childhood, adolescence, or adulthood.
Another limitation of the study was the use of an archival data set. The researcher
attempted to immerse himself in the environment in which the data was collected to familiarize
himself with the intake process, the data collection process, and the significance of the
information being collected. However, the researcher had no control over the data collection
process which could present potential limitations such as representation of targeted population,
accuracy of information, and accuracy of clinical diagnoses. Many participants did not complete
specific assessments which presented an issue for the researcher when conducting analyses
resulting in a large number of cases excluded from the study.
Lastly, a limitation to be considered relates to the diagnoses of the participants.
Participants included in the study represented a wide range of psychiatric diagnoses each with
varying levels of representation. Additionally, participants with co-occurring substance abuse
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issues were kept in the sample as long as they also had a primary diagnosis of a psychiatric
disorder. This has the potential to have impacted the outcomes of the analyses. Causality can not
be inferred due to the non-experimental nature of this study.
Implications for Future Research
Considering the results of this study and associated limitations, there are several
implications for further research. First, future studies should optimize sample size in order to
achieve a larger representation of the population. This will provide a stronger model through
which to examine the relationships between the variables. Next, this study was a cross-sectional
investigation using information from one point in time. In the future, repeated measures or
longitudinal investigations may be beneficial to better understand the trends that exist within a
specific population and will provide a more comprehensive understanding of the variables of
focus. Additionally, the research may benefit from the examination of adverse childhood
experiences and their impact on medication adherence to better understand if there is an
association between the two. By continuing to improve models used on this population, best
practices could be developed and implemented not only in the clinic in Mexico City, but could
be tested in other clinics in the area, other clinics in the country, and outside of the country.
Conclusion
This study investigated the relationship between depression, stressors, disclosure to
family members of HIV status, social support, impulsivity, and exposure to abuse on medication
adherence. The purpose of this study was to add to the existing body of literature regarding the
determinants of medication adherence to ART among HIV-positive individuals. Findings from
this study suggest that both exposure to abuse and impulsivity may negatively impact medication
adherence, however, findings were not consistent across the analyses in the study possible due to
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sample size and uneven groups in several independent variables and the dependent variable.
Future research can focus on improving the validity of the study by increasing the sample size
and ensuring that groups are adequately distributed among the variables. This study emphasizes
the importance of interprofessional collaboration, early prevention and detection of medication
nonadherence, and the role of counselors in delivering services to address complex issues in
healthcare, specifically HIV and AIDS.
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